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Summary 
 
The protozoan parasite Trypanosoma brucei, which causes human sleeping sickness, has to 
adapt to rather different environments as it cycles between the mammalian host and the tsetse 
fly vector. This adaptation is mediated by changes in trypanosome gene expression, which are 
mainly regulated at the post-transcriptional level. Proteins with an RNA-binding "Puf" domain 
are important for post-transcriptional control by modulation of mRNA stability and regulation 
of translation in other species. This suggested that Puf domain proteins might also have a 
similar role in trypanosomes. In addition to the previously characterized TbPUF1 (Hoek, 
Zanders et al. 2002) I have identified eight more PUF genes in the T. brucei genome. A 
comparison of the characteristic RNA binding domain of T. brucei PUF proteins suggested 
that they bind related but distinct targets. Interestingly, each of the PUF protein has an 
orthologue in Trypanosoma cruzi and Leishmania major. Phylogenetic analysis suggested that 
there were several kinetoplastid PUF proteins before separation from the eukaryotic lineage. 
Depletion of each of the nine T. brucei PUF proteins by RNA interference did not result in an 
obvious phenotypic change. Furthermore, PUF1 knock out procyclic cell lines were viable, 
indicating that this PUF protein is not essential for in vitro growth. Additionally, double RNAi 
analyses suggested that the proteins tested did not share redundant functions in T. brucei. 
Microarray studies comparing wild-type cells with cells where PUF levels have been 
perturbed (either by RNAi or overexpression) revealed one putative mRNA target for PUF5: 
CAP17 (corset associated protein 17) mRNA is downregulated upon overexpression of PUF5 
in the insect form of the parasite. Interestingly, PUF5 overexpression was also lethal for 
procyclic cells. Multiple mRNAs which associated with PUF proteins in mRNP complexes 
were identified. PUF5 for example, selectively binds to mRNAs encoding for amino acid 
transporters in bloodstream form cells. Attempts to identify PUF interaction partners have so 
far failed. The effect of PUF proteins on global protein expression level was also investigated 
using two-dimensional gel electrophoresis approach. A few proteins which were differentially 
regulated upon RNAi or knockout of PUF proteins were identified. These results indicated that 
PUF proteins in T. brucei, as is true for PUF proteins in general, are involved in regulating 
gene expression. 
Zusammenfassung 
 
Die Schlafkrankheit wird durch den Parasiten Trypanosoma brucei hervorgerufen. Dieser 
einzellige Erreger wird durch die Tsetse-Fliege von einem Säugerwirt zum nächsten 
übetragen. Die hohe Adaptionsfähigkeit des Erregers beruht auf der Regulation der 
Genexpression, die bei Trypanosomen hauptsächlich post-transkriptionell abläuft. Proteine mit 
einer RNS-bindenden „Puf“ Domäne spielen in anderen Eukaryonten eine wichtige Rolle in 
der post-transkriptionellen Kontrolle; sie modulieren die Stabilität der RNS und regulieren die 
Translation. Es ist zu erwarten, dass PUF Proteine diese Rolle auch in Trypanosomen haben. 
Zusätzlich zum charakterisierten TbPUF1 (Hoek, Zanders et al. 2002) wurden während dieser 
Arbeit acht weitere PUF Proteine in T. brucei identifiziert. Ein Vergleich der RNS-bindenden 
Domäne lässt vermuten, dass PUF Proteine in T. brucei ähnliche aber unterschiedliche mRNS 
binden. Interessant ist, dass orthologe PUF Proteine auch in Trypanosoma cruzi und 
Leishmania major vorkommen. Phylogenetische Analysen deuten darauf hin, dass 
kinetoplastide PUF Proteine schon vor der Abspaltung von der eukaryotischen 
Abstammungslinie existierten. Die Expression jedes einzelnen PUF Proteins wurde mitttels 
RNAi gehemmt. Dies führte jedoch nicht zu offensichtlichen phänotypischen Veränderungen 
in T. brucei. Die gleichzeitige Hemmung der Expression von zwei PUF Proteinen hatte 
ebenfalls keinen ersichtlichen Phänotyp zur Folge und lässt vermuten, dass PUF Proteine 
keine redundanten Funktionen in T. brucei ausüben. Auch die gezielte Inaktivierung des PUF1 
Gens mittels „Knockout“ hatte keine Folgen. Desweiteren konnten Microarraystudien, die 
Wildtypzellen mit PUF-RNAi oder -überexprimierenden Zellen verglichen, eine Ziel-mRNA 
für PUF5 identifizieren. Die Menge an CAP17 (corset-associated protein 17) mRNA wird bei 
Überexpression von PUF5 in prozyklischen Zellen reduziert. Auch ist die Überexpression von 
PUF5 für T. brucei tödlich. Zudem konnte gezeigt werden, dass verschiedene mRNS 
assozieren mit PUF Proteinen in mRNP Komplexen. PUF5 zum Beispiel bindet spezifisch 
RNS, die Aminosäuretransporter kodieren. Versuche, PUF-Interaktionspartner in T. brucei zu 
finden, blieben erfolglos. Der Einfluss von PUF Proteinen auf die globale Proteinexpression 
wurde mittels zweidimensionaler Gelelektrophorese untersucht. Die Expression einiger 
Proteine verändert sich in PUF-RNAi und PUF1 knockout Zell-Linien. Diese Resultate lassen 
darauf zurückschliessen, dass PUF Proteine auch in Trypanosomen in die Kontrolle der 
Genexpression involviert sind. 
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1. Introduction 
 
1.1. Trypanosomes 
Trypanosomes are flagellated protozoa belonging to the order of Kinetoplastida. The name 
of this group is derived from the kinetoplast, a microscopically visible structure of 
thousands of interlocked circles formed by their mitochondrial DNA, known as kinetoplast 
DNA (kDNA) (Shlomai 2004; Liu, Liu et al. 2005). Phylogenetic analyses based on 18S 
rRNA genes indicate that kinetoplastids branched very early from the eukaryotic lineage 
and therefore display some peculiar and unique features. Members of the family 
compartmentalize the first seven glycolytic steps in a peroxisome-like organelle, called the 
glycosome (Opperdoes 1987).  Polycistronic transcription and the subsequent trans-
splicing of spliced leader (SL) RNA to the pre-mRNA is another characteristic feature of 
trypanosomatids (Parsons, Nelson et al. 1984). Furthermore, there is no reproducible 
evidence for defined RNA polymerase II promoters (with the exception of the SL RNA 
promoter) or for developmental regulation of polymerase II transcription (Clayton 2002). 
Mitochondrial RNA in trypanosomes undergoes dramatic modifications by editing (Stuart, 
Schnaufer et al. 2005). The ability to escape the humoral immune response by expressing a 
changing repertoire of variant surface glycoprotein (VSG), a process called antigenic 
variation, is another characteristic trait (Borst 2002). Interestingly, the glycosyl 
phosphatidyl inositol membrane anchor (GPI anchor), relevant to all eukaryotes, was first 
discovered in trypanosomatids (Ferguson, Homans et al. 1988). The study of these 
organisms has revealed novel systems which were subsequently found to be widespread 
and important to general eukaryotic biology. 
 
1.1.1. Genus Leishmania 
Members of the genus Leishmania are the causative agents of leishmaniasis, which affects 
many vertebrates, including humans, dogs and several rodent species. The primary vectors 
transmitting Leishmanias are sandflies. Leishmaniasis currently threatens 350 million men, 
women and children in 88 countries around the world, with 1-2 million people infected 
every year. The various types of leishmaniasis (cutaneous, mucocutaneous and visceral) 
are confined primarily, but not exclusively, to Central and South America, central Africa, 
and parts of southern and central Asia (from WHO internet site: www.who.int). 
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1.1.2. Trypanosoma cruzi 
Trypanosoma cruzi causes Chagas disease (also called American Trypanosomiasis) and is 
widely distributed throughout South and Central America. 1-2 million people are infected 
every year. The insect vector (Triatoma) for Chagas disease ingests amastigotes or 
trypomastigotes when it feeds. In the vector, the parasite reproduces asexually and 
metacyclic trypomastigotes reside in the vector’s hindgut. The vector defecates on the 
host’s skin while it feeds, and the metacyclic trypomastigotes enter the host’s body, most 
often being “rubbed in” to the vectors bite or the mucous membranes of the eye, nose, or 
mouth (from www.who.int). 
 
1.1.3. Trypanosoma brucei 
Three subspecies of Trypanosoma brucei have so far been recognized; T. b. brucei, T. b. 
gambiense and T. b. rhodesiense. They are all widely distributed in tropical Africa, where 
their vectors, Tsetse flies (Glossina spp.) can also be found. T. b. brucei is not pathogenic 
to humans but causes a disease called nagana in African wild and domestic ruminants. T. b. 
brucei is routinely used as a laboratory model organism for other kinetoplastids. T. b. 
gambiense and T. b. rhodesiense are the causative agents of sleeping sickness (Human 
African Trypanosomiasis). T. b. gambiense is found in central and West Africa. It causes 
chronic infection, which does not mean benign. A person can be infected for months or 
even years without obvious symptoms of the disease emerging. But when the symptoms 
finally emerge, the disease is already at an advanced stage. T.b. rhodesiense is found in 
southern and east Africa. It causes more acute infection that emerges after a few weeks. 
These parasites are more virulent than the T. b. gambiense and the disease develops more 
rapidly, which means that it can be more quickly detected clinically. The incidence of 
sleeping sickness may approach 300,000 to 500,000 cases per year, and it is fatal unless 
treated (from www.who.int). 
 
1.1.4. Trypanosoma brucei life cycle 
The life cycle of T. brucei involves transmission between a mammalian host (bloodstream 
form) and an insect vector (procyclic form). Trypanosomes undergo a series of 
differentiation events in order to adapt to these distinct environments (Fig.1.1.). Apart from 
morphological restructuring, changes in surface coat and biochemical adaptation, the 
parasites also alternate between replicating and cell cycle arrested forms. 
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1.2. Gene expression          
Gene expression is a multi-step process which begins with gene transcription and RNA 
processing. Translation of the messenger RNA (mRNA) is then followed by folding, post-
translational modification and targeting of the protein. Mechanisms of transcription have 
been analyzed in great detail in some model organisms such as the budding yeast 
Saccharomyces cerevisiae, mouse and human. Whereas prokaryotes have a single DNA-
dependent RNA polymerase, eukaryotic organisms harbor three such enzymes in the 
nucleus (RNA pol I-III). Transcription regulators and co-factors have been described 
which modulate transcription efficiency at the level of transcription initiation. Chromatin 
organization can also modulate the efficiency of transcription by allowing or restricting 
access to distinct genomic loci. After transcription initiation, the nascent mRNA undergoes 
three types of processing events: a special nucleotide is added to its 5’ end (capping), 
intron sequences are removed from within the mRNA molecule (splicing), and the 3’ end 
of the mRNA is generated (cleavage and polyadenylation). Some of the RNA processing 
events that modify the initial mRNA transcript (for example, those involved in RNA 
splicing) are carried out primarily by special small RNA molecules. Once an mRNA has 
been correctly processed, it is escorted to the cytosol by proteins. To initiate translation in 
eukaryotes, initiation factors recognize and bind to the cap structure, and a small ribosomal 
subunit binds to the mRNA molecule at a start codon. Subsequently, a large ribosomal 
subunit will bind to form a functional ribosome, and thereby initiates the elongation phase 
Fig.1.1. Schematic of the T. brucei 
life cycle, taken from (Matthews 
2005).  
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of protein synthesis. The mRNA molecule progresses codon by codon through the 
ribosome in the 5’-to-3’ direction until one of three stop codons is reached. A release factor 
then binds to the ribosome, terminating translation and releasing the newly synthesized 
polypeptide. 
 
Many steps in the pathway from gene to protein are regulated to control gene expression. 
Control of transcription initiation usually predominates (transcriptional control). However, 
post-transcriptional and –translational regulatory processes are also important. These 
processes include (1) attenuation of the RNA transcripts by its premature termination, (2) 
splicing, (3) control of 3’-end formation by cleavage and poly-A addition, (4) RNA 
editing, (5) nuclear export, (6) localization of certain mRNAs to particular compartments 
of the cell, (7) mRNA translation, (8) regulated mRNA degradation, (9) protein folding, 
(10) protein modification and localization, and (11) protein degradation. 
 
1.2.1. Gene expression in Trypanosomatids 
1.2.1.1. Introduction 
Regulation of gene expression is a means to adapt to different environments, with different 
temperatures, nutrients and defence systems (e.g. of the host). Control of gene expression 
can be exerted on several different layers; in trypanosomatids however, most regulatory 
pathways act at post-transcriptional level. To understand this phenomenon, one has to take 
a closer look at the trypanosome gene organization. 
 
1.2.1.2. Gene organization, transcription and RNA processing 
In trypanosomatids, protein coding genes are tandemly linked, almost never interrupted by 
introns, and separated by short intergenic regions; exceptions which have introns are the 
genes encoding poly(A) polymerase  (Mair, Shi et al. 2000), ATP-dependent DEAD/H 
RNA helicase, and two hypothetical proteins that are predicted to be capable of RNA 
binding (Ivens, Peacock et al. 2005). The majority of genes are transcribed 
polycistronically by an α-amanitin sensible RNA polymerase II. Surprisingly, despite 
enormous effort to identify RNA pol II promoters, no sequences displaying typical 
characteristics of such promoters have been found in trypanosomatids, the only exception 
being the SL RNA promoter (Luo, Gilinger et al. 1999; Gilinger and Bellofatto 2001). 
Analyses of the Leishmania major 269-kb chromosome I reveal a striking organization of 
the 79 genes found on this chromosome. Fifty genes are lined up one after another on one 
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strand and the other remaining 29 are packed adjacent to each other on the opposite strand 
(Myler, Audleman et al. 1999). Similar types of genomic organization are found in other 
chromosomes of T. cruzi and T. brucei (Andersson, Aslund et al. 1998; El-Sayed, Hegde et 
al. 2000; Berriman, Ghedin et al. 2005). Following transcription the polycistronic RNA 
precursor has to be cleaved to create the individual mature mRNA transcripts. This process 
involves two coupled cleavages: one at the 5’-end, with associated trans-splicing, and a 
further downstream cleavage with polyadenylation of the 3’-end (Ullu, Matthews et al. 
1993; Matthews, Tschudi et al. 1994; Liang, Haritan et al. 2003). The process of trans 
splicing was discovered more than two decades ago when analyzing different variant 
surface glycoprotein (VSG) mRNAs in Trypanosoma brucei. It was found that all these 
VSG mRNA carry a common 39-nucleotide sequence, namely the spliced leader (SL) 
sequence (Boothroyd and Cross 1982). This SL sequence derives from a small capped 
RNA, the SL RNA, and has later been found on all trypanosome mRNAs (Milhausen, 
Nelson et al. 1984; Agabian 1990). 
 
1.2.1.3. mRNA stability and degradation 
Regulatory sequences in 3’-untranslated regions (UTRs) are involved in mediating either 
mRNA stability or degradation of the respective mRNA. Many genes with regulatory 3’-
UTRs have been investigated in trypanosomatids. Examples from T. cruzi include the 
genes coding for amastin, tuzin, GP72, GP85, GP82, and the genes encoding small and 
large mucins (Nozaki and Cross 1995; Teixeira, Kirchhoff et al. 1995; Di Noia, D'Orso et 
al. 2000; Brittingham, Miller et al. 2001); in Leishmania protein A2 and the major surface 
proteins MSPL, MSPS, and MSPC contain 3'-UTR regulatory elements (Ramamoorthy, 
Swihart et al. 1995; Charest, Zhang et al. 1996; McCoy, Beetham et al. 1998; Myung, 
Beetham et al. 2002). Regulatory 3’-UTR elements have been best characterized in T. 
brucei. Most differentially regulated transcripts analyzed to date encode for proteins 
involved in energy metabolism or for surface proteins of the parasite, these two categories 
being fundamentally different in the two life cycle stages. Thus, the fructose bisphophate 
aldolase mRNA is at least 6-fold more abundant in bloodstream trypomastigotes than in 
procyclic forms and the 3’-UTR is responsible for the regulation (Clayton 1985; Hug, 
Carruthers et al. 1993; Hotz, Lorenz et al. 1995). The genes for the cytosolic and 
glycosomal phosphoglycerate kinases (PGK) of T. brucei are found in a compact tandem 
array together with a third PGK-related gene, PGKA, which is expressed at low level. 
Expression of the two PGK genes (PGKB and PGKC) is differentially regulated in the life 
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cycle of T. brucei: the glycosomal PGK (PGKC) and its mRNA are abundant in the 
mammalian stage of the cycle but not in the insect stage, whereas the reverse is found for 
the cytosolic PGK (PGKB) and its mRNA (Gibson, Swinkels et al. 1988). Similarly, two 
hexose transporters (THTs) are developmentally regulated by their 3’-UTRs (Hotz, Lorenz 
et al. 1995), with THT1 being expressed exclusively in the bloodstream and THT2 in the 
procyclic stage. A large group of genes with regulatory 3’-UTRs include the major surface 
proteins VSG, EP and GPEET. A VSG 3’-UTR has been shown to cause a 20-fold higher 
expression of reporter gene in bloodstream forms than in procyclic forms (Berberof, 
Vanhamme et al. 1995) and the 3’-UTRs of T. brucei procyclic form surface protein 
mRNAs, EP and GPEET, are examples with well-characterized regulatory motifs (Furger, 
Schürch et al. 1997; Hotz, Hartmann et al. 1997; Schürch, Furger et al. 1997; Drozdz and 
Clayton 1999; Quijada, Guerra-Giraldez et al. 2002). 
 
1.2.1.4. Post-translational control of gene expression in trypanosomes 
First studies on the protein degradation machinery (i.e. proteasome) in trypanosomes 
already started a decade ago (Hua, To et al. 1996). It was demonstrated that the proteasome 
is implicated in stage-specific transformation in T. cruzi (Gonzalez, Ramalho-Pinto et al. 
1996) and T. brucei (Mutomba and Ching 1998). Furthermore, regulation of the cellular 
concentration of cyclins, important regulators of the cell cycle, is also mediated by 
proteasome activity (Van Hellemond and Mottram 2000; Van Hellemond, Neuville et al. 
2000). 
 
 
1.2. RNA binding proteins 
Throughout its lifetime, from biogenesis to translation and finally degradation, a changing 
repertoire of RNA binding proteins (RBPs) can bind to a particular mRNA. In this sense, 
mRNAs generally exist as messenger ribonucleoprotein (mRNP) complexes, rather than as 
single entities. A nascent mRNA is already bound by RBPs that co-transcriptionally 
mediate 5’ end capping, splicing, and editing; 3’ cleavage and polyadenylation; and quality 
control of the mRNA (Gott and Emeson 2000; Neugebauer 2002; Reed 2003). 
Translocation of mRNAs trough nuclear pores is also mediated by RBPs (Vinciguerra and 
Stutz 2004), and once in the cytoplasm, some mRNAs are localized to specific cellular 
regions by an interplay of various motor and mRNP adaptor proteins (Singer 2003; Van de 
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Bor and Davis 2004). In general transcripts are translationally repressed during localization 
(Huang and Richter 2004). Many RBPs that are involved in translation and regulation of 
translation also control mRNA transport and stability (Kuersten and Goodwin 2003; 
Kuersten and Goodwin 2005). Finally, an exonuclease-mediated degradation machinery 
destroys mRNAs either by normal, nonsense-mediated (NMD), and nonstop decay (NSD) 
pathways (Parker and Song 2004). 
 
While many classes of RBPs have been described in higher eukaryotes, only a few trans-
acting factors have been identified in trypanosomes. Poly(A)-binding protein (PABP1), a 
major cytoplasmic mRNA binding protein, was characterized in T. cruzi, T. brucei and 
Leishmania spp. (Batista, Teixeira et al. 1994; Hotchkiss, Nerantzakis et al. 1999; Bates, 
Knuepfer et al. 2000). PABP1 has been implicated in translation control and mRNA 
turnover by interaction with the poly(A)-tail at the 3’-end of all mRNAs. A role in 
ribosomal RNA (rRNA) biogenesis was suggested for the two proteins p34 and p37, that 
associate with 5S rRNA in T. brucei (Zhang and Williams 1997; Pitula, Ruyechan et al. 
2002). Interestingly, both proteins interact with NOPP44/46, the major tyrosine-
phophorylated nucleolar RBPs family in T. brucei (Das, Peterson et al. 1996; Pitula, Park 
et al. 2002). Furthermore, a nuclear serine/arginine (SR)-rich trypanosomal protein 
(TSR1), that contains two RNA recognition motifs (RRMs), has been implicated in trans-
splicing in T. brucei (Ismaili, Perez-Morga et al. 1999; Ismaili, Pérez-Morga et al. 2000). 
SL RNA binding activity was also shown for XB1 and TcSR, which were suggested to be 
involved in trans- (XB1) and cis-splicing (TcSR) in T. cruzi (Xu, Wen et al. 2001; Portal, 
Espinosa et al. 2003). Many mRNA binding proteins were shown to be involved in RNA 
editing in T. brucei: these are the guide RNA binding proteins gBP16 (Hayman and Read 
1999; Pelletier, Miller et al. 2000; Pelletier and Read 2003) and gBP21 (Koller, Muller et 
al. 1997; Allen, Heidmann et al. 1998; Muller, Lambert et al. 2001; Muller and Goringer 
2002), the oligo(U) binding protein TbRRG1 (Vanhamme, Perez-Morga et al. 1998), the 
RNA editing associated protein 1 (TbEAP1) (Madison-Antenucci and Hajduk 2001), the 
endo-exoribonuclease TbMP42 (Brecht, Niemann et al. 2005),  and the mitochondrial 
RBPs MRP1 and MRP2 (Vondruskova, van den Burg et al. 2005). Two RBPs with an 
RRM, TcUBP-1 and TcUBP-2 (U-rich binding protein), were shown to have a 
destabilizing effect on specific mRNAs in T. cruzi (D'Orso and Frasch 2001; D'Orso and 
Frasch 2002). The T. brucei homologues of TcUBP-1 and TcUBP-2, TbUBP1 and 
TbUBP2, are also implicated in posttranscriptional gene regulation (C. Hartmann, 
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unpublished data). The recently completed genomes of T. brucei, T. cruzi and L. major 
(referred to here as the tri-tryp) contain many predicted proteins with RRM domains. 
Trypanosoma cruzi has nearly twice as many RRM-type proteins (139) as T. brucei (75) 
and L. major (80) (De Gaudenzi, Frasch et al. 2005).  RNA binding proteins are also 
involved in the 3’-5’ mRNA degradation pathway: TbRRP4, TbRRP40, and TbCSL4 all 
have S1 RNA-binding activity and are part of the exosome complex (Estévez, Kemp et al. 
2001). A role in differentiation from bloodstream to insect form stage of T. brucei was 
demonstrated for the two zinc finger proteins TbZFP1 and TbZFP2  (Hendriks, Robinson et 
al. 2001; Hendriks and Matthews 2005). And finally, TbPUF1, a member of the PUF 
family of RNA binding proteins was identified in T. brucei (Hoek, Zanders et al. 2002). 
What are PUF proteins? 
 
 
1.3. PUF proteins 
Over the years, investigation of gene expression regulation in eukaryotes has mainly 
focused on the control of transcription initiation, which is the essential step for nearly all 
organisms. However, it has become evident that post-transcriptional control of gene 
expression is also of importance. Alternative splicing generates different mRNAs which 
then give rise to proteins with divergent functions (reviewed in (Black 2003)). Aberrant 
mRNAs need to be eliminated before they are translated into erroneous proteins (Wagner 
and Lykke-Andersen 2002; Weischenfeldt, Lykke-Andersen et al. 2005). And some 
mRNAs are only needed transiently, and therefore their degradation has to be tightly 
controlled (Wilusz and Wilusz 2004). Localization of mRNAs is another level of 
regulation: some mRNAs are only functional in certain parts of the cell (St Johnston 2005). 
In eukaryotic cells, every part of an mRNA can contain sequence elements responsible for 
its regulation. Some 5’UTR regulatory elements are involved in translational control (for 
review, see (Wilkie, Dickson et al. 2003), (Meijer and Thomas 2002)). However, the 
region between the termination codon and poly(A) tail- the 3’ untranslated region, or 
3’UTR- has emerged as preeminent (for review, see (Wickens, Bernstein et al. 2002)). 
Sequences in the 3’UTR are bound by trans-regulatory proteins, which control mRNA 
stability, translation and localization. PUF proteins are one family of these 3’UTR 
regulatory proteins. The two founding members of this family are Drosophila Pumilio and 
C. elegans FBF (Barker, Wang et al. 1992), (Zamore, Williamson et al. 1997), but they 
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have now been found in virtually all eukaryotes examined, including vertebrates, plants, 
yeast, protozoan, and slime molds (Wickens, Bernstein et al. 2002). In Drosophila, Pumilio 
protein is known to bind the 3’UTR of hunchback mRNA, leading to an increase in the rate 
of deadenylation and repression of translation of this mRNA (Murata and Wharton 1995; 
Wreden, Verrotti et al. 1997). Similarly, in C. elegans, FBF protein binds the 3’UTR of 
fem-3 mRNA and leads to repression of translation (Zhang, Gallegos et al. 1997). 
Furthermore, PUF proteins in yeast and slime molds also repress expression of target 
mRNAs by binding to sequences in the 3’UTR (Souza, da Silva et al. 1999; Olivas and 
Parker 2000; Tadauchi, Matsumoto et al. 2001). Thus, the PUF family proteins are 
commonly 3’UTR repressors. 
 
1.3.1. Sequence and Structural Similarity 
Puf proteins are characterized by the presence of eight consecutive repeats (Puf repeats) of 
approximately 40 amino acids (Zamore, Williamson et al. 1997; Wharton, Sonoda et al. 
1998; Tadauchi, Matsumoto et al. 2001; Wang, Zamore et al. 2001). This Puf repeat region 
is necessary and sufficient to bind to specific RNA sequences and to provide many of the 
protein’s biological functions. The recently determined structures of human and 
Drosophila Pumilio reveal a striking, extended crescent (Fig.1.2.) (Edwards, Pyle et al. 
2001; Wang, Zamore et al. 2001). 
 
 
 
All of the individual Puf repeats form nearly identical three-helix triangles; these lie next to 
each other to form the elongated structure. The inner surface of the crescent carries the 
Fig.1.2. Structure of Drosophila Pumilio Puf 
domain taken from (Edwards, Pyle et al. 2001). The 
Puf domain contains eight tandem Puf repeats 
(shown in different colors), which are composed of 
three helices (H1, H2, and H3).  
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conserved aromatic and charged amino acid residues that are likely to bind RNA, and the 
outer surface can contact other proteins. PUF proteins bind selectively to their target 
mRNAs. Individual PUF proteins bind to different RNA sequences and are affected 
differentially by base changes in a single sequence (Bernstein, Hook et al. 2005). Human 
and fly PUF proteins bind to mutant RNA derivatives of hunchback with different affinity, 
despite the two proteins being 80% identical (Zamore, Williamson et al. 1997). 
Nevertheless, all known PUF-binding sites posses a common tetranucleotide motif, UGUR 
(Murata and Wharton 1995; Zamore, Williamson et al. 1997; Zhang, Gallegos et al. 1997; 
Wharton, Sonoda et al. 1998; Tadauchi, Matsumoto et al. 2001). Using a yeast three-hybrid 
system (Bernstein, Buter et al. 2002) it was demonstrated that a single spacer nucleotide 
downstream of UGUR confers binding specificity of C. elegans FBF and PUF-8 
(Opperman, Hook et al. 2005). 
 
1.3.2. PUF interacting partners  
PUF proteins do not act on their own to control mRNAs, but instead interact with other 
protein partners. To date, only three PUF binding partners have been found, one belonging 
to the Nanos family (Kraemer, Crittenden et al. 1999; Sonoda and Wharton 1999) and 
another being a member of the CPEB (cytoplasmic polyadenylation element binding 
protein) family (Luitjens, Gallegos et al. 2000). The third interaction partner Drosophila 
Brat, is a member of the NHL protein family and is recruited to hunchback mRNA through 
a ternary complex of Pumilio, Nanos and the mRNA (Sonoda and Wharton 2001). Co-
immunoprecipitation approaches suggest a fourth group of PUF interacting partners: DAZ 
(Deleted in AZoospermia) and DAZ-like proteins were shown to interact with Human 
Pumilio-2 (Moore, Jaruzelska et al. 2003). These common PUF protein partners have so far 
been only detected in metazoans, but not in unicellular eukaryotes such as yeast, even 
though these contain multiple PUF proteins. 
 
1.3.3. PUF targets 
Although members of the PUF family are all found throughout the eukaryotic lineage, only 
few of their mRNA targets have been identified so far (Wickens, Bernstein et al. 2002). 
For example, in Drosophila, the PUMILIO protein binds to the Nanos response element 
(NRE) of maternal hunchback mRNA and represses its translation at the posterior part of 
the early embryo (Murata and Wharton 1995; Wreden, Verrotti et al. 1997). Fem-3-binding 
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factors (FBFs), the C. elegans Puf homologs, repress fem-3 translation and thereby regulate 
the switch from spermatogenesis to oogenesis. FBFs are also involved in maintaining 
germline stem cells through binding and inhibition of gld-1 mRNA expression (Camargo, 
Almeida et al. 1997; Zhang, Gallegos et al. 1997; Crittenden, Bernstein et al. 2002). Two 
specific mRNA targets have been described for yeast Puf proteins: Puf3p regulates 
turnover of COX17 mRNA in vitro by binding to its 3’-UTR (Olivas and Parker 2000), and 
Puf5p interferes with HO endocluonease expression (Tadauchi, Matsumoto et al. 2001). 
Recently, work by (Gerber, Herschlag et al. 2004) has shown that the five Puf proteins in 
yeast each bind specifically to distinct and functionally related mRNAs. Puf1p and Puf2p 
bind preferentially to mRNAs that encode membrane-associated proteins; Puf3p 
selectively interacts with mRNAs encoding mitochondrial proteins; and Puf4p and Puf5p 
specifically bind to mRNAs encoding nuclear components (Gerber, Herschlag et al. 2004). 
 
1.3.4. Protist Puf proteins 
Members of the Puf protein family have so far been described only in a few protozoan 
organisms, namely T. brucei, T. cruzi, and Plasmodium falciparum. The first PUF protein 
described in T. brucei was TbPUF1 (Hoek, Zanders et al. 2002), which is also the first 
member of the PUF family identified in an early branching eukaryote. TbPUF1 was found 
in a two-hybrid screening to interact with TbESAG8. PUF1 is expressed at equal levels in 
both insect and bloodstream-form parasites. Attempts to disrupt the two PUF1 alleles in 
both forms of the life-stages by classical homologous recombination failed, suggesting that 
PUF1 was an essential gene. However, growth analyses from conditional PUF1 null 
mutant cell lines were not able to conclusively show that PUF1 was essential. Cells that 
overexpressed a tagged version of PUF1 had a significant growth defect and a reduced 
infectivity in mice. Messenger mRNA stability assays showed that TbPUF1 might regulate 
stability of specific expression site (ES) derived mRNAs (e.g. ESAG8 and VSG221) in 
trypanosomes (Hoek, Zanders et al. 2002). These expression sites are found in 
subtelomeric regions and specifically harbor VSG and ESAG (expression site associated 
genes) genes that are transcribed by RNA pol I . Interestingly, the TbPUF1 homologue in 
T. cruzi, TcPUF6, and the two Puf proteins of P. falciparum, PfPuf1 and PfPuf2, were 
shown to specifically bind to the Drosophila hunchback NRE sequence in vitro (Cui, Fan 
et al. 2002; Fan, Li et al. 2004; Dallagiovanna, Perez et al. 2005). 
 
Introduction 
15 
To date, PUF proteins were shown to physically interact with members of three protein 
families (Nanos, CPEB, and Brat). Currently, no homologues of these PUF interactors are 
found in the genome of protozoa. (Hoek, Zanders et al. 2002) suggested that TbPUF1 
interacts with TbESAG8. However, the yeast two-hybrid assays as well co-
immunoprecipitation studies demonstrating this interaction were somewhat preliminary. 
First, TbPUF1 resides solely in the cytoplasm (Hoek, Zanders et al. 2002), whereas 
TbESAG8 is localized to the nucleolus (Hoek, Engstler et al. 2000). Moreover, previous 
yeast-two hybrid studies by (Perez-Morga and Pays 1999) suggested an interaction 
between TbESAG8 and TbPIE8 (putative interacting with ESAG8), despite a 
mitochondrial localization of the latter. It is possible that TbESAG8 appears frequently as a 
false positive in yeast-two hybrid studies. Overall, only a few PUF binding partners are 
characterized and so far none have been conclusively found in protozoans. 
 
 
1.4. Aims of the work described in this thesis 
This work was started because post-transcriptional control of gene expression is crucial in 
Kinetoplastids, and very little is known about the regulatory proteins. The presence of a 
family of RNA binding proteins (Puf proteins), which are important for post-transcriptional 
control by modulation of mRNA stability and regulation of translation in other species 
suggested that they might also have this function in trypanosomes. Furthermore, TbPUF1 
had been suggested to be essential in T. brucei and to play a role in virulence.  The aim of 
this thesis was to further investigate the function of TbPUF1, and to identify other Puf 
proteins in T. brucei and to functionally characterize them. Another question to address 
was the identification of mRNA targets of the PUF proteins in T. brucei. The method of 
choice to identify these targets was to employ T. brucei microarrays. Another task was to 
look for PUF binding partners. Furthermore, I also took advantage of the advanced two-
dimensional differential gel electrophoresis (DIGE) to study the role of PUF proteins in 
global protein expression, this being done towards the end of my thesis. A detailed 
understanding of PUF protein functions in T. brucei will certainly shed light on the 
evolutionary conservation (and hence importance) of these proteins throughout the 
eukaryotic lineage. 
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2. Materials and methods 
 
2.1. T. brucei cell culture 
2.1.1. Determination of cell density  
The T. brucei culture was briefly homogenised by shaking the culture flask. 10µL was 
placed under a cover slip on a Neubauer improved counting chamber (Migge). The cells 
from two crossing 16-square-fields were counted, and their average was multiplied by 1 x 
104, which gave the number of cells in 1mL of the culture. Dilutions were made to 
maintain the cultures below 7 x 106 and 1-2 x 107/mL for bloodstream and procyclics 
respectively. 
 
 
 
2.1.2. Bloodstream-form trypanosome culture  
Bloodstream-form (bf) trypanosomes were cultured in an incubator (Heraeus Instruments) 
at 37°C, 5% CO2, in a humified atmosphere. The bottle caps were loosely tied to allowed 
gaseous exchange. Cells were harvested at densities up to 3 x 106 cells/mL* in 
supplemented HMI-9 medium. All culture work was done under sterile conditions in a 
laminar flow hood. For cryopreservation, 500µL aliquots of culture in log phase of growth 
(1-2 x 106 cells/aliquot) were added to an equal volume of 20% glycerol in HMI-9 in 
cryovials. The vials were wrapped in a thick layer of soft tissue paper and stored overnight 
at –80°C. This treatment allowed gradual freezing after which the tubes were transferred to 
cryoboxes in a liquid nitrogen tank. To restart cultures the cells were thawed at room 
temperature (RT) and transferred to 5mL HMI-9 medium. 
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HMI-9 
αIMDM (Gibco)   17.66g/L 
NaHCO3 (Roth)    36mM 
Hypoxanthine (Serva)   1mM  
Na-pyruvate (Serva)    1mM  
Thymidine (Sigma)    160mM 
Bathocupronsulphonate (Serva) 50 mM 
 
Supplemented HMI-9 medium, 500mL 
HMI-9 supplemented with: 
δHeat-inactivated FCS 10%(v/v) 
Penicillin/Streptomycin   50U/L (5mL of Penicillin-Streptomycin mix, Sigma) 
L-Cysteine-HCL.H2O   1.5mM (5mL of stock solution)  
β-mercaptoethanol (Sigma)  0.14% (7.2µL in 5mL, filtered, added fresh) 
 
α Iscove’s Modified Dulbecco’s Medium, no supplements  
δ FCS was heat-inactivated by incubating it at 56ºC for 30min. 
 * Bloodstream trypanosomes grow at low densities compared to procyclic trypanosomes, 
but easily die if the culture is overgrown and usually take long to restart growing. 
 
2.1.3. Stable transfection of bloodstream form trypanosomes 
All centrifugation steps were done at 2,000 rpm for 10min at RT (Heraeus). 1 x 107  cells 
from a log phase culture (1-2 x 106 cells/mL) were centrifuged, suspended in 10mL of 
Cytomix and centrifuged again.  The pellet was resuspended in 0.5mL of Cytomix and 
transferred to a BTX cuvette at RT. About 10µg of sterile linearised plasmid DNA were 
added and mixed by pipeting up and down and subjected to a single electric pulse on a 
BTX electroporator set for peak discharge at 1.6kV, and resistance timing mode R2 (24 
Ohm). The cells were then transferred to 25mL of warm (supplemented) HMI-9, 
distributed in 24-wells microtiter plates (0.5mL/well) and incubated overnight at 37ºC. The 
next day, 0.5mL of medium with the appropriate antibiotics (depending on the background 
of the cells and twice the concentration of the selection antibiotic) was added to each well. 
Stable clones were established between 5-7 days with adequate cell densities. The new 
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clones were scaled up to 5mL of supplemented HMI-9 for further culture and downstream 
analysis. 
 
Cytomix 
EGTA    2mM  
KCl     120mM  
CaCl2     0.15mM 
K2HPO4/KH2PO4   10 mM (pH 7.6) 
HEPES    25 mM  
MgCl2    5 mM 
Glucose   0.5% (w/v) 
BSA     100µg/mL 
Hypoxanthine (Serva)  1mM   pH 7.6 (with NaOH) 
The medium was filter-sterilized and stored at 4°C. 
 
2.1.4. Procyclic form trypanosome culture 
Procyclic form trypanosomes were cultured in tightly closed flasks in a 30oC-room at 
densities between 0.1-10 x 106 cells/mL* in supplemented MEM-Pros. All work was done 
under sterile conditions in a laminar flow hood. Cryopreservation and thawing was done as 
for bloodstream form but in supplemented Mem-Pros medium with 20% glycerol and at 
about 2 x 106 cells/aliquot.  
 
MEM-Pros  pH: 7.4 
CaCl2    265mg/L  NaH2PO4  0.14 g/L  
KCl    0.4g/L   HEPES  7.14g/L 
MgSO4.7H2O   0.2g/L   L-Arg-HCl  126mg/mL 
NaC1    6.8g/L   LCys-Cys  24mg/L 
L-His-HCl.H2O  42mg/L  L-Gln   292mg/L 
L-Ile   52mg/mL  L-Tyr    100mg/L 
L-Leu    52mg/L  L-Val    46mg/L  
L-Lys    73mg/L  L-Pro    600mg/L  
L-Met    15mg/L  Adenosine   12mg/L  
L-Phe    100mg/L  Ornithine-HCl  10mg/L  
L-Thr    48mg/L  L-Try    10mg/L 
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10mL of MEM non-essential amino acids (Gibco), 10mL of MEM Vitamins (Sigma) and 
10mg of Phenol Red were added to 1L of medium and the pH adjusted. The medium was 
filter sterilised, aliquoted at 450mL and kept at 4ºC. 
 
Supplemented MEM-Pros medium, 500mL 
MEM-Pros with: 
Heat-inactivated FCS (Gibco)  10% (v/v) 
Hemin     7.5 mg/L (1.5mL of stock solution) 
Penicillin/Streptomycin   50U/L (5mL of Penicillin-Streptomycin (5000U/ml), 
Sigma) 
 
Hemin stock: 0.25% in 0.1M NaOH, autoclaved and stored at 4ºC. *Cultures of procyclic 
trypanosomes under 1 x 105 cells/mL do not grow unless in conditioned medium, which is 
obtained after centrifugation and sterile filtration of a well-established culture of procyclic 
cells. It contains undetermined factors that enable growth of low-density cultures. 
 
2.1.5. Stable transfection of procyclic trypanosomes 
All centrifugation steps were done at 2,000 rpm for 10 min at RT (Beckckman). Cells were 
grown to log phase of culture (3-8 x 106cells/mL). 2 x 107 cells were washed once in 10mL 
of ice cold ZPFM (Zimmerman post-fusion medium). The pellet was resuspended in 
0.5mL of ice-cold ZPFM and transferred to a lmL cuvette (BTX) on ice. 10µg of sterile 
linearized plasmid DNA was added and mixed by pipetting up and down. The cells were 
electroporated as described for bloodstream forms (Section 2.1.4.). The cells were then 
transferred to 10mL Mem-Pros with appropriate antibiotics according to cell background 
and incubated overnight at 30ºC. The following day, selection antibiotic was added to this 
culture and 1.5mL distributed to each well on the top row of a 24-well microtiter plate. 
500µL of conditioned medium (i.e., medium obtained from a previous culture, centrifuged 
and sterile-filtered) with appropriate antibiotics, was aliquoted into each of the remaining 
wells. The cells were distributed vertically following the principle of limiting dilution: 
0.5mL of the culture in the first well on the first row was transferred to the second well. 
The dilution was done consecutively for the third and fourth well, always with cells from 
the immediate-upper well. Stable clones were established between 7-14 days with adequate 
cell densities. The cultures were often scaled up in volume (e.g. 5mL) for further culture 
and downstream analysis. 
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5X ZPFM 
NaCl  123mM 
KCI  8mM  
Na2HPO4 8mM  
KH2PO4  1.5mM  
MgAc   1.5mM  
Ca(OAc)2  90µM  
pH: 7.0 (with NaOH or acetic acid) 
The medium was filter-sterilized and stored at 4ºC. 
 
2.1.6. Antibiotics used for selection of recombinant trypanosomes 
• Phleomycin (Cayla): Stock solution: 5mg/mL, stored at 4°C. 
Concentrations used in culture: 0.2µg/mL (bloodstream); 0.5µg/mL (procyclics). 
• Hygromycin B (Life technologies): Stock solution: 50mg/mL, stored at 4°C. 
Concentrations used in culture: 15µg/mL (bloodstream); 50µg/mL (procyclics).  
• Neomycin (G418, Gibco). Stock solution: 50mg/mL, stored at 4°C. Concentrations 
used in culture: 0.5µg/mL (bloodstream); 12µg/mL (procyclics);  
• Blastidicin (Invitrogen). Stock solution: 5mg/mL, stored at –20°C. 
Concentration used in culture: 10µg/mL (procyclics); 5µg/mL (bloodstream). 
• Puromycin (Sigma). Stock solution 1mg/mL, stored at 4°C. 
Concentration used in culture: 0.2ug/mL (bloodstream); 1 µg/mL (procyclics) 
2.1.7. Tetracycline-inducible cells 
The 427-449 and 427-1313-cell lines (both bloodstreams and procyclics) have integrated 
the Tn10 tet repressor gene and express it constitutively. The cell line 427-1313-514 
additionally expresess T7 polymerase. These cells can be transfected with inducible 
trypanosome expression vectors, i.e. constructs containing a promoter with two operator 
sites where repressor molecules bind hence preventing promoter driven transcription. 
When Tetracycline (Tet) is added to the culture medium, it binds the repressor molecules, 
which then fall off the operator. This allows transcription of a given gene under the control 
of the (inducible) promoter. Tet-inducible vectors used in this work were pHD615, 
pHD617 (Biebinger, Wirtz et al. 1997), pHD918 (Estévez, Kemp et al. 2001), p2T7-177-
Hyg (LaCount, Bruse et al. 2000), p2T7TA-blue (Clayton, Esteacutevez et al. 2005), and 
pHD1621 (p2T7-177-Bsd, Corinna Benz). 
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2.2. Basic methods for nucleic acids and proteins analysis 
2.2.1. Phenol extraction 
One volume (vol) of a 1:1 mix of Roti®-Phenol (Roth, equilibrated in TE buffer) and 
chloroform was added to DNA or RNA solution in TE or water respectively. The samples 
were gently mixed by inversion and centrifuged for 5 min at 13,000 rpm at RT. The 
aqueous phase was then ethanol precipitated. 
 
TE buffer 
Tris-HCI   10mM  (pH 7.5) 
EDTA   1mM 
2.2.2. Ethanol precipitation and washes 
To a DNA or RNA sample, 10% of its volume of 3M NaAc (pH 5.2) and 2.5 volumes of 
100% ethanol were added. After 30 min at -20ºC, the samples were centrifuged at 13,000 
rpm for 15 min at 4ºC. The pellet was washed with 70% ethanol and air-dried. The pellet 
was then resuspended (TE/water) and incubated at 55ºC for 10min to fully dissolve the 
sample. Samples were then stored in NaAc/ethanol mix at -20ºC (DNA) or at  -80ºC 
(RNA). The samples were centrifuged and washed just before use. 
 
2.2.3. TCA precipitation 
About 100µL of protein sample was diluted 1:6 in 1X PBS containing complete protease 
inhibitor, Roche Applied Science (total volume 600µL). One-quater volume (150µL) of 
100% TCA containing deoxycholate (DOC) was added, the sample mixed and incubated 
overnight on ice. The sample was vortexed briefly and centrifuged at 13,000 rpm for 15 
min at RT. The pellet was washed with 3 volumes of original sample volume of ice-cold 
acetone, incubated at RT for 10 min, then centrifuged at 13,000 rpm for 15 min. The pellet 
was air-dried at room temperature for 10 min and stored at –20oC or dissolved in 1 X 
Laemmli buffer (Section 2.8.4), denatured for SDS–PAGE (Section 2.8.3).  
 
100% TCA     100% TCA + DOC 
TCA 100g in 41mL H2O   100% TCA  10mL  
DOC   40mg  
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2.3.  Recombinant DNA technology 
2.3.1. PCR  
100ng of plasmid or genomic DNA were used as template in a 50 µL-PCR reaction. The 
reaction mix included 1X PCR-buffer, 0.2 mM dNTPs, 1pmol each reverse and forward 
primers and 0.5 U of Taq-DNA pol (Amersham). A reaction volume of 25µL was used for 
colony PCR (Section 2.4.3.3.). The tubes were placed in a thermocycler 
(RoboCycler®Gradient 96, Stratagene); the standard PCR steps were: DNA denaturation at 
94ºC for 1-5 min, 20-30 cycles of denaturation, primer annealing and elongation, and 10 
min of elongation at 72ºC. The annealing temperature depended on the primer pairs used.  
 
The PCR reaction was analyzed by running 5 µL in an ethidium-bromide-stained agarose 
gel. If there were a single PCR product, the PCR product was then purified using a 
QIAquick PCR purification Kit (Qiagen Inc.). If there were more than one product, the 
whole sample was electrophoresed and the specific product (determined by size) purified 
from the agarose gel (NucleoSpin Extract, Macherey Nagel). For cloning purposes, the 
primers were often designed with restriction endonuclease sites. These enabled the ligation 
of the product into a vector DNA cut with the same restriction enzymes that generate 
compatible ends (sticky end-ligation). 
 
10X Taq-DNA pol buffer 
Tris-HCl   100 mM  (pH 9.0) 
KCl    500mM 
MgCl2   15mM 
Triton X-100   1% (v/v) 
 
dNTPs 
2µL of each of 100mM dATP, dGTP, dTTP and dCTP were added to an eppendorf tube 
and the volume made up to 100µL with sterile water.  This resulted in a final concentration 
of 200µM for each dNTP. 5µL of this solution was used in a 50µL PCR reaction.    
 
Forward and reverse primers 
1µL of each primer (100pmol/µL) was used in a 50µL PCR reaction 
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2.3.2. Restriction endonuclease digests 
Each enzyme was used in conditions recommended by the manufacturer - Amersham or 
New England BioLabs. Usually, 2-3U of enzyme were used to digest 1µg of DNA, taking 
care that the enzyme (usually stored in glycerol-containing buffers) constituted less than 
10% of the total reaction volume. Restriction enzyme digests were incubated for 2 h, at the 
optimum temperature. In case of digestion at DNA-ends (like PCR products), the reactions 
were incubated overnight. Cleavage of DNA substrate with two restriction endonucleases 
simultaneously (double digestion) was done in the buffer that resulted in the maximal 
activity for both enzymes. If no one buffer met the buffer requirements of both enzymes, 
the reactions were performed sequencially. First, cleavage was done with the restriction 
endonuclease that requires the lower salt reaction conditions, then salt concentration was 
adjusted (using a small volume of a high concentration salt solution) to approximate the 
reaction conditions of the second restriction endonuclease. The second enzyme was added 
and incubated to complete the second reaction. 
 
2.3.3. Creation of blunt ends in DNA fragments 
Following restriction enzyme digestion that generated 5’- or 3’-protruding ends, the 
desired fragment was gel purified (section 2.3.6.) and the overhangs filled-in as described 
below. 
 
2.3.3.1. Removal of 3’-overhangs  
About 3-5µg of digested DNA was incubated (30 sec, 37oC) with 1µL of T4-DNA 
polymerase (Amersham, 4U/µL), 1X DNA polymerase buffer and 1µL of dNTPs in a 20 
µL-reaction was added for further 5min of incubation. The reaction was stopped by heat 
inactivation (75ºC for 10min). 
  
2.3.3.2. Fill-in of 5’-overhangs 
Approximately 3-5µg of DNA was incubated (15min at RT) with 1µL of the Klenow 
fragment of DNA Polymerase (USB, 5U/µL), 2µL of 10X buffer L (Amersham) and 1µL 
of dNTPs in a 20µl reaction volume. The enzyme was heat-inactivated (75ºC for 10min). 
 
dNTPs 
dATP, dGTP, dTTP and dCTP  2mM (final concentration of each) 
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10X Buffer L (Amersham)  
Tris-HCI   100mM  (pH 7.5) 
MgCl2     100mM 
DTT     10mM 
 
2.3.4. Dephosphorylation of 5’-ends 
The removal of a phosphate group from a linearised plasmid with Calf Intestinal 
Phosphates (CIP, Boehringer Mannheim, 1 U/µL) prevents it from self-ligation and lowers 
background. About 2 µL of CIP were added to the restriction digest and incubated at 37ºC 
for 15 min.  The tube was transferred to 55ºC for 15 min. The reaction was stopped by 
addition of 2µL of 500mM EDTA and heat inactivation (75ºC for 10 min). The DNA was 
purified by using the Qiagen Miniprep kit, or by gel extraction.  
 
2.3.5. Agarose gel electrophoresis 
Gels were prepared by melting 0.8-1.8 g agarose (Gibco) in 100mL of TAE buffer in a 
microwave oven. Ethidium bromide (approximately 30 µg, from a stock solution at 
10mg/mL) was added for UV visualization. DNA molecules fractionated on 1 X TAE 
buffer for 30-90 min at 100-120V, and were then visualized and photographed under UV 
light. 
 
TAE buffer 
Tris-HCl   40mM 
EDTA   1mM (pH 8.0) 
Acetic acid   0.11% 
 
2.3.6. Purification of DNA fragments from agarose gels 
All steps were at RT. The purifications were done using a NucleoSpin® Extract kit 
(Macherey Nagel) following the manufacturer’s instructions. 
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2.3.7. Ligation of DNA fragments 
DNA inserts excised from plasmid or PCR-generated were cloned into a vector prepared as 
described in sections 2.3.2 to 2.3.6. DNA fragments were ligated using 1U of T4-DNA 
ligase, with molar vector:insert DNA ratios of about 1:3. 1 µL each of 10X ligation buffer 
and T4-DNA-ligase were added and the volume made upto 10µL with Nuclease–Free 
water. The ligation reactions were incubated at 16ºC overnight. 
 
10X Ligation buffer 
Tris-HCl   0.5M (pH 7.6) 
MgC12   0.1M 
ATP    10mM 
DTT    10mM 
 
2.4. Amplification of recombinant DNA in bacteria 
2.4.1. Preparation of competent cells 
All centrifugation steps were carried out at 4ºC. 
 
Escherichia coli DH5α cells were taken from a frozen stock at -80ºC and incubated 
overnight at 37ºC on an antibiotic-free LB-agar plate. A single colony was picked and used 
to inoculate 5mL of ψB medium. The culture was incubated at 37°C with vigorous shaking 
for about 2 h (OD550 ~ 0.3). The cells were then transferred to 100mL of medium pre-
warmed to 37oC and incubated for another 2 h (OD550 ~ 0.48). The culture was transferred 
into a Corex® tube, incubated on ice for 5 min, and then centrifuged at 6,000 rpm for 5 
min (Sorvall, SS34 rotor). The bacterial pellet was re-suspended in 40mL of cold TfbI 
buffer, incubated on ice for 5 min and centrifuged again at 6,000rpm for 5min. The pellet 
was re-suspended in 4mL of cold buffer TfbII, incubated on ice for 20min then aliquoted 
200µL/tube for storage at –80oC.  
 
DH5α Cells (Promega) 
Genotype: supE44, ∆lacU169(∆80lacZ∆M15), hsdR17, gyrA96, thi-1, relAl 
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ψB medium 
Trytone peptone (Difco)     20 g/L 
Yeast extract (Difco)      5 g/L 
MgSo4 (20mM)      5 g/L 
pH 7.6 (with KOH) 
The medium was autoclaved and stored at RT 
For agar plates: BactoTM AGAR (Difco)   15 g/L  
 
TfbI buffer      TfbII buffer 
KAc   30mM     MOPS  10mM 
RbCl2  100mM    CaCl2   75mM 
CaCl2   10mM     RbCl2   10mM 
MnCl2  50mM     Glycerol  15% 
Glycerol  15%     pH 6.5 (0.1 M KOH) 
pH 5.8 (0.2M acetic acid)   
Both buffers were sterile-filtered and stored at 4ºC. 
 
2.4.2 Transformation of competent cells with recombinant DNA 
Approximately 5µL of a ligation reaction were mixed with a 25 µL aliquot of competent 
E.coli DH5-α (thawed on ice). The mix was incubated on ice for 30 min and heat-shocked 
in a water bath at 42ºC for 45 sec. 200µL of ψB medium was added and the cells incubated 
at 37oC for 45 minutes. An aliquot of the transformation was spread out on LB-agar plates 
containing appropriate antibiotic (section 2.4.3.1.). 
 
Luria Bertani (LB) Medium  LB Medium + Agar (LB-Agar) 
Tryptone   10g/L  LB Medium 
Yeast extract   5g/L  Bacto-Agar   15g/L 
NaCl (170mM)  10g/L 
2.4.3. Selection of transformants 
2.4.3.1. Antibiotic selection  
To select for transformants, an aliquot of the transformation reaction was spread on LB-
Agar plates containing appropriate antibiotic. Ampicillin was used at a final concentration 
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of 100µg/mL; kanamycin at 30µg/mL and chloramphenicol at 25µg/mL. The antibiotics 
were added after the medium had cooled to about 50°C. 
 
2.4.3.2. Blue–white selection of recombinant bacteria 
Whenever a cloning plasmid contained a polylinker (MCS: multiple cloning site) within 
the β-galactosidase gene, the cloning of an insert into this site disrupted the β-galactosidase 
gene. Bacteria that are transformed with this recombinant DNA do not metabolize 
galactose, whose metabolic product is blue in the presence of IPTG. These colonies appear 
white after an overnight growth at 37ºC. Colonies transformed with wild type plasmid 
(plasmid without insert) give blue colonies. Plasmids with this color-selection system used 
in the work presented in this thesis are pBlueScript (Stratagene) and p2T7TA-blue. 
 
The transformed bacteria were streaked on LB-Agar plates supplemented with 1.5mg of X-
Gal (a metabolizable analog of galactose) (80µL of a 2% stock solution was spread on a 
plate ready to use) and 1mg of IPTG (5µL of a 830mM stock solution was spread on the 
plate). Development of blue color of colonies was sometimes enhanced by a 1-2h 
incubation at 4ºC. A number of white colonies were screened for DNA inserts by colony 
PCR (Section 2.4.3.3), DNA mini-preps (see 2.5.1) or restriction digests and agarose gel 
analysis. Putative clones were then confirmed by DNA sequencing. 
 
2% X-Gal      830 mM IPTG 
2 mg/mL in Dimethylformamide   2 g/10mL 
Stored in the dark at -20ºC    Stored at -20ºC 
 
 
2.4.3.3. Screening bacterial transformants by colony-PCR 
A PCR cocktail composed of PCR buffer, dNTPs, primers, and Taq-DNA polymerase and 
sufficient for the number of colonies to be screened was prepared. Twenty-four bacterial 
colonies were picked with the aid of a 10µL-pipette tip and resuspended individually in 
20µL of the PCR cocktail. Each colony was also patched onto a separate plate for 
reference. The reaction was incubated at 94oC for 10 min to lyse the cells and to inactivate 
nucleases. The amplification was done for 20-30 cycles in the RoboCycler® as follows: 
94oC for 1 min, 55oC for 1 min, and 72oC for 1 min. The final extension was performed at 
72oC for 10 min after which the reaction was held at 4oC. The products (10µL) were 
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electrophoresed on a 1-1.2% ethidium bromide stained-agarose gel and visualized under 
UV. Clones were identified, larger quantities of DNA made (mini- or maxi DNA preps) 
and 8% glycerol stocks made and kept at –80oC. 
 
 
2.5. Analysis of transformants 
2.5.1. Plasmid DNA mini-preps  
All centrifugation steps were performed at RT. 
Up to 24 bacterial colonies were picked and resuspended individually into 3mL of LB 
supplemented with appropriate antibiotic. The cultures were incubated at 37oC with 
vigorous shaking for 12-16 hours. 1.5mL of the overnight cultures were centrifuged in an 
eppendorf tube at 13,000 rpm for 1 min. The pellet was resuspended in alkaline lysis buffer 
of the Eppendorf FastPlasmidTM Mini kit (Eppendorf AG, Hamburg, Germany) and 
processed according to the manufacturers instructions. The DNA minipreps were screened 
for the desired clones by restriction endonuclease digestion, agarose gel analysis and 
confirmed by DNA sequencing at Medigenomix GmbH (Martinsried, Germany). A 100µL 
aliquot of bacterial culture was mixed in a ratio of 1:1 with 20% glycerol in LB and kept at 
-80ºC. 
 
2.5.2. Maxi-preparation of plasmid DNA  
All centrifugation steps were performed at 4oC. 
After an overnight growth at 37ºC, 200mL of bacterial culture were centrifuged at 6,000 
rpm for 10min (Sorvall, GS3 rotor). The resulting pellet was carefully re-suspended in 
10mL of cold buffer P1 and transferred to an SS34-rotor centrifuge tube. 10mL of freshly 
prepared 0.2N NaOH/1% SDS were added, mixed and allowed to lyse the cells for 5 min. 
The lysate was mixed with 10mL buffer P3 and incubated on ice for 20 min. Large cellular 
fragments were separated by centrifugation at 13,000 rpm for 30min (Sorvall, SS34 rotor). 
The clear supernatant was passed through a column (Tip500, Qiagen) previously 
equilibriated with buffer QBT. The column was washed twice with 30mL of buffer QC and 
the DNA eluted with 15mL of buffer QF into a clean SS34-tube. The DNA was 
precipitated with 10.5mL of isopropanol and centrifuged at 11,000 rpm for 30min. The 
pellet was air-dried and re-suspended in 500µL of TE buffer and transferred into an 
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eppendorf tube. The maxi-prep DNA was used for a variety of downstream processes, e.g. 
transfections.  
 
Buffer P1       Buffer P3  
Tris-HCI   50mM (pH7.8)   KAc   3M 
EDTA   10mM (pH8.0)   Glacial HAc  (50% v/v)  
RNase A   100mg/L (Sigma)   pH 4.8 (acetic acid) 
 
Buffer QBT   Buffer QC   Buffer QF  
NaCl   0.75M  NaCl  1M  NaCl   1.25M 
MOPS  50mM  MOPS  50mM   MOPS  50mM 
Ethanol  15%  Ethanol 15%  ethanol  15% 
TritonX-100  0.15%  pH 7.0    pH 8.2 
pH 7.0 
 
2.5.4. Extraction of T. brucei genomic DNA 
All centrifugation steps were performed at RT. 
Between 3-10 x 107 cells were centrifugued at 2000 rpm for 10min. The cell pellet was 
resuspended in 150µL of Tris-EDTA-LiCl-Triton X-100 (TELT) buffer, mixed gently by 
inversion and incubated for 5 min. 150µL of equilibrated phenol-chloroform was added, 
mixed by vigorous shaking and centrifuged at 13,000 rpm for 5 min. The upper aqueous 
phase was aspirated into a new tube containing 500µL of 100% ethanol. The tube was 
swirled gently for 15 seconds, incubated for 5min and centrifuged at 13,000 rpm. The 
DNA pellet was washed with 70% ethanol and air-dried. The pellet was then resuspended 
in 30-100µL of TE and incubated with RNase A for 30min. Ethanol precipitation was 
repeated to remove DNase A. 
 
TELT Buffer 
Tris.Cl  50mM (pH 8.0) 
EDTA  62.5mM (pH 9.0) 
LiCl  2.5mM 
Triton X-100 4% (v/v) 
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2.5.5. Southern blotting and hybridization conditions 
Between 5-10µg of genomic DNA was subjected to a single or double restriction enzyme 
digest in a total volume of 100µL in conditions recommended by the suppliers. After an 
overnight digestion, a fresh aliquot of enzyme(s) was added and the reaction continued for 
2 h to ensure complete digestion. The reaction was concentrated to 20µL by ethanol 
precipitation and loaded onto an 0.8% agarose gel. Electrophoresis was run overnight at 
about 20V in 1 X TAE. The gel was photographed under UV light, rinsed briefly in water 
and depurinated in a tray of 0.25 M HCl with gentle agitation for 10 min. The gel was 
tranferred into denaturing solution and gently agitated for 30min. It was rinsed briefly in 
water and placed in neutralisation solution for 30 min with gentle agitation. The DNA was 
then transferred overnight to a nylon membrane (Hybond-N+, Amersham) by downward 
capillary blotting using a Turbo blotterTM apparatus (Schleicher & Schuell) and 10X SSC 
as transfer buffer. The blot was rinsed in 5 X SSC for 5min, air-dried and UV-crosslinked 
(UV Stratalinker 1800, Stratagene). The blot was prehybridized for 2 h in pre-hybridization 
solution. Hybridization was done overnight at 60ºC with 100ng of denatured α-[32P]-
labeled probe (Section 2.6.4) in hybridization solution. After hybridisation the membrane 
was washed 3 times each for 15 min in 10mL of wash buffer at 50oC.  The blot was 
exposed on an X-Omat X-ray film with intensifying screens and kept at –80oC for 2-5 
days. 
 
Denaturing Solution    Prehybridisation Solution 
NaCl  1.5 M    5X Denhardt’s reagent 
NaOH  0.5M    6X SSC 
      0.5% SDS  
Herring Sperm DNA (Serva) 10µg/mL 
 
Neutralizing Solution    Hybridization solution 
NaCl   1.5 M    5X Denhard’s reagent 
Tris-HCl  0.5 M (pH7.2)   6X SSC 
EDTA  1mM    0.5% SDS (w/v) 
Herring Sperm DNA  10µg/mL 
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20X SSC       
NaCl  3M     
Na-Citrate 0.3M 
pH 7.2 
 
50X Denhardt’s Solution    Southern blot wash buffer 
BSA    1% (w/v)   1X SSC 
Ficoll    1% (w/v)   0.5% SDS (w/v) 
Polyvynilpyrrolidone  1% (w/v) 
Filtered and stored at -20ºC 
 
DNA for probes or Herring sperm DNA was denatured by incubation at 95-100ºC for 5-
10min and immediately put on ice. The probe was saved and stored at -20ºC and again 
denatured before use. 
 
2.5.6. Cloning of PUF constructs 
The open reading frames of all nine TbPUF genes were amplified by PCR using 427 pc 
genomic DNA and primers listed in Table 2.1. Fragments for RNAi targeting were PCR 
amplified using RNAi primers listed in Table 2.1. 
 
 
Table 2.1. Primers 
ORF, size 
 
primers sequence comments 
TbPUF1 
Tb10.70.2800 
1701bp 
 
 
RNAi, 389 bp  
 
 
CZ1769 5’ 
CZ1770 3’ 
CZ2136 3’ 
CZ1811 3’ 
 
CZ2210 5’ 
CZ2211 3’ 
GATCAAGCTTATGTCGTCGGATGAGG 
CGAGGATCCCTATGTTCCTTTCTTG 
GATCGGATCCTGTTCCTTTCTTGCTT 
GATCCCCGGGTGTTCCTTTCTTG 
 
GATCctcgagGCGCCAGAACATCTTAAAGC 
GATCggatccCGACTTTGCCTCCACTCTTC 
HindIII 
BamHI 
BamHI, -stop  
SmaI, -stop 
 
XhoI 
BamHI 
TbPUF2 
Tb10.389.0940 
2544 bp 
 
RNAi, 501bp 
 
 
CZ2280 5’ 
CZ2281 3’ 
CZ2282 3’ 
 
CZ2283 5’ 
CZ2284 3’ 
GATCaagcttATGTCTGGTTGGGACG 
GATCggatccCTACAGCGTTGGCATG 
GATCgttaacCAGCGTTGGCATGCAG 
 
CGAGCTAAAGGATTGCCTTG 
TCCTGCATCATAAGCACGAG 
HindIII 
BamHI 
HpaI, -stop  
TbPUF3 
Tb10.100.0190 
1758 bp 
 
 
RNAi, 555bp 
 
CZ2130 5’ 
CZ2131 3’ 
CZ2132 3’ 
CZ2274 3’ 
 
CZ2206 5’ 
CZ2207 3’ 
GATCAAGCTTATGTGTTCCAGTTCCC 
GATCAGATCTTCAGCCGGAGAGCGGT 
GATCAGATCTGCCGGAGAGCGGTTGG 
GATCGTTAACGCCGGAGAGCGGTTGG 
 
GATCGTCGACCGGACGATAATGAGCGAAATTG 
GATCAGATCTTGCAATCGTGTCAATGGTTTTG 
HindIII 
BglII 
BglII, -stop 
HpaI, -stop 
 
SalI 
BglII 
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TbPUF4 
Tb927.6.820 
2967 bp 
 
 
RNAi, 459bp 
 
 
CZ2133 5’ 
CZ2134 3’ 
CZ2135 3’ 
CZ2258 3’ 
 
CZ2208 5’ 
CZ2209 3’ 
GATCAAGCTTATGGAGGCCAGTGCCGAGGTG 
GATCGGATCCTCATCCCTTCCTGCCGCGTTG 
GATCGGATCCTCCCTTCCTGCCGCGTTGCG 
GATCGTTAACTCCCTTCCTGCCGCGT 
 
GATCCTCGAGGCATCTGCAACGAACTCAAAAAGC 
GATCGGATCCAGCACATCAAGCATCGTCTGCAC 
HindIII 
BamHI 
BamHI, -stop 
HpaI, -stop 
 
XhoI 
BamHI 
TbPUF5 
Tb927.7.4730 
1293 bp 
 
 
RNAi, 436bp 
 
 
CZ2259 5’ 
CZ2260 3’ 
CZ2261 3’ 
CZ2529 3’ 
 
CZ2262 5’ 
CZ2263 3’ 
GATCAAGCTTATGCTTCGTAGGGGTG 
GATCGGATCCTCACTCACCGACTGCC 
GATCGTTAACCTCACCGACTGCCCCG 
GATCGGATCCCTCACCGACTGCCCCGG 
 
CTTGCTGTGAGTTCGCCATA 
TGACGGGATCACACACTGTT 
HindIII 
BamHI 
HpaI, -stop 
BamHI, -stop 
TbPUF6 
Tb10.26.0140 
2532 bp 
 
RNAi, 479bp 
 
 
CZ2275 5’ 
CZ2276 3’ 
CZ2277 3’ 
 
CZ2278 5’ 
CZ2279 3’ 
GATCAAGCTTATGAGTTCAACCAAAG 
GATCGGATCCTCACTCGGCATCGAAG 
GATCGTTAACCTCGGCATCGAAGTGC 
 
TTATTCAGCGTGCAGTGGAG 
AAAAATGGCTTCCTCCTGGT 
HindIII 
BamHI 
HpaI, -stop 
TbPUF7 
Tb11.01.6600 
2115 bf 
 
RNAi, 583bp 
 
 
CZ2285 5’ 
CZ2286 3’ 
CZ2287 3’ 
 
CZ2288 5’ 
CZ2289 3’ 
GATCAAGCTTATGCCAAAAATGCGTTTAG 
GATCTGATCATCATTCGGCCGTTTTG 
GATCGTTAACTTCGGCCGTTTTGAAAG 
 
GACCCTGTTTCGTCACCTGT 
TCATAAGATGCTTGCGTTGC 
HindIII 
BclI 
HpaI, -stop 
 
 
TbPUF8 
Tb927.3.2470 
1815 bp 
 
RNAi, 303bp 
 
 
CZ2248 5’ 
CZ2249 3’ 
CZ2250 3’ 
 
CZ2251 5’ 
CZ2252 3’ 
GATCAAGCTTATGGGTAAAACTAACAC 
GATCGGATCCTTATTTCTTGGGGAGA 
GATCGTTAACTTTCTTGGGGAGAACC 
 
TCAACAGTCCCTTTGGACATC 
TTGCAATGAGACCCACGTAA 
HindIII 
BamHI 
HpaI, -stop 
TbPUF9 
Tb927.1.2600 
2004 bp 
 
 
 
 
 
 
RNAi, 371bp 
CZ1857 5’ 
CZ1858 3’ 
CZ1889 5’ 
CZ2137 3’ 
CZ1886 3’ 
 
CZ1920 3’ 
 
 
CZ2037 5’ 
CZ2038 3’ 
GATCAAGCTTATGGAAGTACGCGATG 
GATCGGATCCCTAACATTCTCCGTCA 
GATCGAGCTCATGGAAGTACGCGATG 
GATCAGATCTACATTCTCCGTCATCA 
GATCCTCGAGGTTAACACATTCTCCGTCATCA 
 
GAAGATCTGGCGTAGTCTGGGACGTCGTATGGG 
TAACATTCTCCGTCATC 
 
GATCGTCGACGGATGCCGCTTTAGTGG 
GATCAGATCTCAAGGCAACATGGGCGA 
HindIII 
BamHI 
SacI 
BglII, -stop 
XhoI, HpaI, 
 -stop 
BglII, -stop, 
 +HA-tag 
 
SalI 
BglII 
 
 
ORF-PCR products were cloned into pHD615 (for expression in pc cells, (Biebinger, Wirtz 
et al. 1997)), pHD617 (bf, (Biebinger, Wirtz et al. 1997)), and into pHD918 (for TAP-
tagging, (Estévez, Kemp et al. 2001)). RNAi-fragments were cloned either into p2T7-177-
Hyg (LaCount, Bruse et al. 2000), p2T7TA-blue (Clayton, Esteacutevez et al. 2005), or 
pHD1621 (Corinna Benz). Following plasmids were generated (Table 2.2.): 
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Table 2.2. Plasmids 
pHD1377 
pHD1378 
pHD1396 
pHD1538 
pHD615 + PUF1-cds @ HindIII/BamHI 
pHD617 + PUF1-cds @ HindIII/BamHI 
pHD918 + PUF1-cds (w/o stop) @ HindIII/(SmaI/HpaI) 
p2T7-177 + PUF1-RNAi @ XhoI/BamHI 
pHD1564 
pHD1565 
pHD1548 
pHD615 + PUF2-cds @ HindIII/BamHI 
pHD617 + PUF2-cds @ HindIII/BamHI 
p2T7TA-blue + PUF2-RNAi @TA-overhang 
pHD1490 
pHD1491 
pHD1539 
pHD1650 
pHD615 + PUF3-cds @ HindIII/(BglII/BamHI) 
pHD617 + PUF3-cds @ HindIII/(BglII/BamHI) 
p2T7-177 + PUF3-RNAi @ (SalI/XhoI)/(BglII/BamHI) 
pHD1621 + PUF3-RNAi @ (SalI/XhoI)/(BglII/BamHI) 
pHD1492 
pHD1493 
pHD1540 
pHD1651 
pHD615 + PUF4-cds @ HindIII/BamHI 
pHD617 + PUF4-cds @ HindIII/BamHI 
p2T7-177 + PUF4-RNAi @ XhoI/BamHI 
pHD1621 + PUF4-RNAi @ XhoI/BamHI 
pHD1556 
pHD1557 
pHD1699 
pHD1652 
pHD1702 
pHD1544 
pHD615 + PUF5-cds @ HindIII/BamHI 
pHD617 + PUF5-cds @ HindIII/BamHI 
pHD1484 + PUF5-cds (w/o stop) @ HindIII/BamHI 
pHD1621 + PUF5-RNAi @ XhoI/BamHI 
pHD918 + PUF5-cds (w/o stop) @ HindIII/HpaI 
p2T7TA-blue + PUF5-RNAi @TA-overhang 
pHD1562 
pHD1563 
pHD1547 
pHD1653 
pHD615 + PUF6-cds @ HindIII/BamHI 
pHD617 + PUF6-cds @ HindIII/BamHI 
p2T7TA-blue + PUF6-RNAi @TA-overhang 
pHD1621 + PUF6-RNAi @ XhoI/BamHI 
pHD1554 
pHD1555 
pHD1543 
pHD1654 
pHD615 + PUF7-cds @ HindIII/(BclI/BamHI) 
pHD617 + PUF7-cds @ HindIII/(BclI/BamHI) 
p2T7TA-blue + PUF7-RNAi @TA-overhang 
pHD1621 + PUF7-RNAi @ XhoI/BamHI 
pHD1552 
pHD1553 
pHD1542 
pHD615 + PUF8-cds @ HindIII/BamHI 
pHD617 + PUF8-cds @ HindIII/BamHI 
p2T7TA-blue + PUF8-RNAi @TA-overhang 
pHD1411 pHD615 + PUF9-cds @ HindIII/BamHI 
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pHD1412 
pHD1456 
pHD1489 
pHD617 + PUF9-cds @ HindIII/BamHI 
pHD918 + PUF9-cds (w/o stop) @ HindIII/HpaI 
p2T7-177 + PUF9-RNAi @ (SalI/XhoI)/(BglII/BamHI) 
 
2.5.7. Knock-out constructs for TbPUF1 and TbPUF9 
A homozygous disruption of TbPUF1 was performed in procyclic T. brucei strain 427. The 
knockout plasmids gim5::NEO and gim5::BSD were taken from (Maier, Lorenz et al. 
2001) and modified as shown in Fig.2.1. T. brucei genomic DNA was used as a template to 
generate by PCR two DNA fragments: one spanning 200 bp (5’-UTR) upstream and 100 
bp downstream of the ATG start codon (300 bp in total) of TbPUF1. The primers used in 
this PCR amplification were CZ2369 and CZ2370 (see Table 2.3.). The second fragment 
was spanning the last 100 bp of ORF up 200 bp of the 3’-UTR (300 bp in total). The 
primers used for this PCR amplification were CZ2371 and CZ2372. These fragments were 
sequentially ligated into plasmids gim5::NEO and gim5::BSD (Maier, Lorenz et al. 2001) 
to flank the neomycin (neo) and blasticidin (bsd) marker cassettes, respectively (Fig.2.1.). 
These flanking homology regions allowed a locus specific recombination between wild-
type chromosomal DNA containing the TbPUF1 gene and linear DNA fragment 
containing the resistance markers. Procyclic form 427 cells were sequentially transfected 
with SacI/ApaI-linearised pHD1639 (PUF1-Bsd) and pHD1641 (PUF1-neo) plasmids and 
selected for double resistance to neomycin and blasticidin. The very same strategy was 
used to construct PUF2-knockout plasmids (pHD1640 and pHD1642). 
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Fig.2.1. Constructs for deleting TbPUF1 and TbPUF9, respectively. 
 
Table 2.3. Primers for TbPUF1 and TbPUF9 knockout constructs: 
CZ2369 5’ 
CZ2370 3’ 
CZ2371 5’ 
CZ2372 3’ 
CZ2412 5’ 
CZ2413 3’ 
CZ2375 5’ 
CZ2376 3’ 
GATCGAGCTCAGAAGAGAAACGGCTC 
GATCACTAGTGTTCAGCAGTTCTTATC 
GATCGGATCCACAGCAGTTTCCAATG 
GATCGGGCCCAACAGTTTTTCTCTAAC 
GTCAGAGCTCGGGTAGAAGTAAAGG 
CTAGGCTAGCAAGAGGGAATGGCCC 
GATCGGATCCAAATAGGCGGCAGAGC 
GATCGGGCCCAAAAGTACATAAGTAC 
SacI 
SpeI 
BamHI 
ApaI 
SacI 
NheI 
BamHI 
ApaI 
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2.6. Isolation and analysis of RNA 
2.6.1. Extraction of T. brucei total RNA 
Total RNA was isolated from 2-4x107 cells from cultures with densities between 1-2 x 106 
cells/mL (bloodstream form) or 3-4 x 106 cells/mL (procyclics). The cells were centrifuged 
at 2,000 rpm for 10 min at RT and the pellet resuspended in 1mL of pegGOLD TriFastTM 
(Peqlap, GmbH). 200µL of chloroform was added and shaken vigorously and the tube 
stood at room temperature for 5 min. The mix was centrifuged at 13,000 rpm for 15min at 
4°C. The aqueous phase was pipetted into 500µL of isopropanol and RNA precipitated for 
about 30 min at RT. For use, the RNA pellet was redissolved into appropriate volume of 
RNAse-free water. Alternatively total RNA was isolated using RNeasy Mini/Midi Kit 
(Qiagen, Hilden, Germany) following the manufacturer’s instructions. 
 
2.6.2. Northern blotting 
Approximately 25µg of total RNA or 4µg of poly(A)+ RNA were precipitated with 1/10 
volumes of 3M NaAc (pH 5.4) and 2.5 volumes of ethanol for 15 min on ice. The tube was 
centrifuged at 13,000 rpm for 20 min at 4oC and the pellet washed with 750µL of 70% 
ethanol. The RNA pellet was dried on a heat block at 37oC for 5 min. 15µL of loading mix 
was added to the pellet and incubated at 37oC for 10 min. The tube was vortexed briefly to 
dissolve the RNA and incubated at 65oC for 10min, chilled on ice for 5 min and loaded on 
a gel. 5µg of molecular size marker (Invitrogen’s 0.24-9.4kb marker) were treated as the 
samples and loaded along side the samples. The RNA was resolved on a 1% 
agarose/formaldehyde gels at 18-20V in 1X MOPS. After electrophoresis, the gel was 
photographed under UV light and the RNA transferred onto a neutral nylon membrane 
(Nytran® Scheicher and Schuell) using the Turbo-blotter apparatus. The RNA was cross-
linked in UV light in a stratalinker (Stratagene). Prehybridization was done for 2 hours at 
65oC in Northern blot Prehybridisation Buffer. Hybridisation was done overnight at 42oC 
with 100ng of α-[32P]-random-prime-labelled DNA probe. The blot was washed once in 
Wash Buffer I at room temperature for 30 min, then once in Wash Buffer II at 42oC for 45 
minutes, and finally once in Wash Buffer III at 42oC for 30 minutes. The blot was exposed 
on an X-Omat X-ray film with intensifying screens and kept at –80oC for 1-5 days. 
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10X MOPS buffer  RNA gel   RNA loading Mix 
MOPS  200mM Agarose 1%(w/v) Formamide 50%(v/v) 
Na-acetate  80mM  Formaldehyde 0.5M  Formaldehyde 6.5%(v/v) 
EDTA  10mM  1X MOPS   1X MOPS 
pH: 7.0       EtBr  10µg/mL 
 
Prehybridisation Buffer   Hybridisation Buffer 
5X Denhard’s reagent   Formamide   50% 
6X SSC     6X SSC 
1% SDS     1% SDS 
Herring Sperm DNA 100µg/mL  Herring Sperm DNA  100µg/mL 
 
Wash Buffer I   Wash Buffer II  Wash Buffer III 
10X SSC   1X SSC   0.1X SSC 
1% SDS   0.5% SDS   0.2% SDS 
 
2.6.3. Random prime labeling of DNA probes 
DNA probe labeling was done using the Prime-It® II Random Primer Labeling Kit 
(Stratagene) following the manufacturers intructions. Briefly, the DNA fragment to be 
labled was diluted to 25ng/mL in TE. 4µL (100ng) was made up to 20µL with sterile water 
and the probe denatured at 95oC, 5 minutes and chilled on ice. To 1.5mL eppendorf tube in 
an ice bath, the following reagents were added in the following order: 
 
10µL Nucleotide mix   
5µL Primers 
20µL  Denatured DNA (100ng)  
1µL  Enzyme solution (Klenow 5U) 
3µL α- [32P]-dCTP (30 µCi) 
11µL Sterile distilled water 
 
The contents were mixed gently by pipetting up and down and span briefly to collect the 
contents at the bottom of the tube. The reaction was incubated at 37oC for 1 hour. The 
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probe was then purified using the Nucleotide Removal Kit (Qiagen), following the 
manufaturer’s instructions.   
 
2.7. Polyclonal antibodies 
2.7.1. Peptide antibodies to TbPUF1 and TbPUF9 
Generation of peptides and immunisation of rabbits were done by Eurogentec (Brussels, 
Belgium). To analyse TbPUF1 and TbPUF9 protein expression peptide-antibodies to a 16 
amino acid region of TbPUF1 and TbPUF9 were generated. The two peptide sequences 
were selected with the help of the PROTEAN program, included in the ‘Lasergene’ 
program package (DNASTAR Inc). PROTEAN is a computer algorithm that can be used 
to predict the topological features of a protein directly from its primary amino acid 
sequence. The computer program generates values for surface accessibility parameters and 
combines these values with those obtained for regional backbone flexibility and predicted 
secondary structure. The output of this algorithm, the antigenic index, is used to create a 
linear surface contour profile of the protein (Jameson and Wolf 1988).  
The C-terminal peptide sequences ‘RELARKNGNQKNKKRW’ (aa-residue 445-460 of 
TbPUF1) and ‘RQQNRRQSHSQPRRQP’ (aa-residue 633-638 of TbPUF9) showed the 
highest antigenic index. 20-30mg of each peptide were synthesized and 5mg were coupled 
to a carrier protein (Hemocyanin, BSA, OVA, THY). Two rabbits were immunized (500 
ng each) with each peptide followed by three individual boosters (again 500 ng each) at 
day 14, 28, and 56. Peptide synthesis, KLH coupling and immunization of the rabbits, were 
done by Eurogentec (Belgium). Serum was taken at day 0 (preimmune, PPI), day 38 (small 
bleeding), day 66 (large bleeding), and day 87 (final bleeding). The specificity and titer of 
the antiserum were tested by Western blotting. 
  
2.7.3. Affinity chromatographic purification of antibodies 
The immuno-affinity matrix Affi-Gel 10 (BioRad 153-6064) was thawed in an ice water 
bath for 30 minutes. Meanwhile, 2mg of peptide was reconstituted in coupling buffer). 
0.5mL of resin was placed in a 15mL falcon tube and the volume made to 10mL with 
water. The tube was inverted several times and centrifuged at 2000rpm for 1 min. The 
supernatant was aspirated and the wash repeated once more with water and then twice with 
coupling buffer. The supernatant was aspirated and the resin incubated with antigen 
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solution overnight at 4oC in a gentle tumbler. The resin was then centrifuged at 2000rpm 
for 1 min, the supernatant aspirated. The resin was washed again with 10mL of blocking 
buffer, centrifuged as before and resuspended in 2mL of blocking buffer. This was 
incubated for 1h at 4°C on a tumbler. The resin was centrifuged again and washed twice 
with PBS, twice with elution buffer and twice with 100mM Tris-HCl (pH 8). The resin was 
resuspended in 1mL of 100mM Tris-HCl (pH 8), transferred to a 10mL disposable column, 
washed with another 1mL of Tris.HCl and transferred to the column and washed with 
10mL of Tris-HCl (pH 8). It was then washed with 10mL of PBS-500 and then with 10mL 
PBS. The serum was passed through the column; the collected flow-through was again 
passed through the same column and finally the resultant flow-through was kept frozen. 
The column was washed with 10mL of PBS and then with 10mL of PBS-250 and finally 
with 10mL of PBS-500. The antibody was eluted with 5X 0.5mL of elution buffer into a 
tube that already contained 90µL of 1M Tris-HCl (pH 9.5) and mixed well. The final pH 
was checked with a pH paper indicator and if necessary, adjusted to pH 7-8. An equal 
volume of cold, sterile glycerol was added, mixed well and the antibodies stored in aliqouts 
at –20oC.  
 
Coupling Buffer 
The coupling buffer should not contain primary amino groups e.g. Tris, glycine. The 
following buffers are recommended at 50mM: HEPES, MOPS, MES, acetate, bicarbonate, 
borate/borax. For the work reported in this thesis bicarbonate buffer was used. 
 
AffiGels 
AffiGel-10 couples proteins best at pH near or below the isoelectric point of the antigen. 
AffiGel-15 couples proteins near or above their isoelectric point. It is best used for acidic 
proteins or peptides but can be used for basic antigens carrying out the coupling in very 
basic buffers, like borate-borax, at a pH 0.5units higher than the isoelectric point. 
  
Blocking buffer     Elution Buffer 
Ethanolamine-NaOH 100mM (pH 8.0)  Glycine 0.1M (pH 2.5) 
 
PBS-250      PBS-500 
PBS containing 250mM NaCl   PBS containing 500mM NaCl 
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2.8. Isolation and analysis of T. brucei proteins 
2.8.1. Extraction of total protein 
All centrifugation steps were done at 4ºC. 2 x 106 cells were centrifuged at 2,500 rpm for 
10 min and washed with PBS (with complete protease inhibitor, Roche Applied Science) 
and re-centrifuged. The supernatant was carefully aspirated leaving about 10-15µL of 
buffer. This was either stored at –20°C till used or an equal volume of 2 X Laemmli buffer 
was added and the sample denatured (by boiling for 95oC for 5 minutes) for SDS-PAGE. 
 
2.8.2. Determination of protein concentration by the Bradford protein 
assay  
The Bradford Assay is a rapid and accurate method commonly used to determine the total 
protein concentration of a sample. The assay is based on the observation that the 
absorbance maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts from 
465 nm to 595 nm when binding to protein occurs. Both hydrophobic and ionic 
interactions stabilize the anionic form of the dye, causing a visible color change. Within 
the linear range of the assay (~5-25 µg/mL), the more protein present, the more Coomassie 
binds. Protein standards containing a range of 0 to 25µg BSA were prepared from a stock 
of 1µg/µL to a standard volume of 1 mL (see Table 2.4). 
 
Table 2.4. Preparation of a standard curve for protein determination 
Tube 1 2 3 4 5 6 
BSA (µL) 0 5 10 15 20 25 
1M NaOH (µL) 50 50 50 50 50 50 
Dist. Water (µL) 950 945 940 935 930 925 
BSA (µg/mL) 0 5 10 15 20 25 
 
The Bradford reaction was initiated by adding 800µL, from the dilution series above, to 
200µL of Bradford dye reagent in corresponding tubes labeled 1B to 6B. The reaction was 
incubated at room temperature for 5 min and the absorbance measured at 595 nm against 
the blank (tube 1B). A standard curve of absorbance versus BSA concentration was 
prepared and used to determine protein concentration in the test samples taking into 
consideration any dilution factor.  
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2.8.3. SDS-PAGE 
About 8mL 12% running gel were poured into a mounted mini protean electrophoresis 
apparatus (BioRad) overlayed with water and allowed to polymerise. 2.5 mL of stacking 
gel were then added and a comb slid between the glass plates. Once polymerised the gel 
was placed in electrophresis chamber and filled up with 1 X running buffer. Trypanosome 
samples (2x106 cells/lane) were loaded, the chamber connected to a power supply and 
proteins fractionated at 150V for about 45 min. 
 
12% Separating gel (15mL)   4% Stacking gel (5mL)  
Gel 30    6mL  Gel 30    0.65mL 
1.5M Tris-HCl (pH 8.8) 3.75mL 0.5M Tris-HCl (pH 6.8)  1.25mL 
H2O    5.25mL H2O     3.05mL 
10% APS   50 µL  10% APS   25µL 
TEMED    10µL  TEMED    10µL 
10X Running buffer, 1L 
Tris (Roth)    30.3g 
Glycine (AppliChem)  188g 
10% SDS   100mL 
pH 8.3 
 
 
2.8.4. Western blotting 
All incubations and washes were at RT and with gentle agitation. Cell pellets of about 
2x106 cells each were resuspended in 1 X Laemmli buffer and denatured on a heating 
block at 95oC for 5 minutes. The samples were fractionated by SDS-PAGE and transferred 
to a polyvinyl diflouropyrolidol (PVDF) membrane (Hybond-P, Amersham). Blotting was 
done at 100V for 1h at 40C in blotting buffer using a BioRad apparatus. The membrane 
was then incubated in blocking buffer (blotto) for 1 hour (RT), washed once for 15 min 
and then twice for 5min with fresh changes of wash buffer. It was then incubated for 1h in 
blocking solution supplemented with antibodies at appropriate dilution. The blots were 
again washed as before to remove unbound primary antibody. The filter was then 
incubated for 30 min with Horseradish peroxidase (HRP)-conjugated secondary antibody 
diluted at 1:1000 in blocking solution. Unbound antibody was washed off with PBS-T (15 
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min x1, then 5 min x4). Specific protein bands were visualized by incubating the 
membrane in ECLTM detection reagents (Amersham) for 1 min and exposing for 10 sec to 
60 min on ECL films. The membranes were stripped for re-probing by incubating in 
stripping buffer for 30 min at 500C and washing for 10 min in excess PBS-T. 
 
Blotting buffer   PBS-T buffer pH 7.6 
Tris   25mM   Na2HPO4   10mM 
Glycine  192mM  KH2PO4   1.8mM 
Methanol  20%     NaCl    140mM 
  KCl    2.7mM 
     Tween-20 (Serva)  0.3% 
 
Blocking solution    
Skimmed milk 10% (in PBS-T)   
 
Stripping buffer  
Tris    62.5mM (pH 6.7)   
SDS    2%     
β-mercaptoethanol 100mM 
 
2 X Laemmli buffer 
Tris.Cl   0.25M (pH 6.8) 
SDS   4%(w/v) 
Glycerol  20%(v/v) 
β-Mercaptoethanol 3%(v/v) 
Bromophenol blue Trace 
 
2.8.5. Coomassie blue staining of SDS-PAGE gels 
All steps were performed at RT. The gel was soaked for 30 min in Coomassie blue staining 
solution (with gentle agitation). Gels were destained at least three times, for 1 h each, in 
high Methanol solution and further in Low Methanol solution for up to 12 h. For record 
purposes, the gel was transferred to a solution with 20% ethanol/10% glycerol for 30-45 
min and then vacuum-dried. 
Materials and methods 
43 
Coomassie blue staining solution 
Coomassie Brilliant Blue R250  0.25%(w/v) 
Methanol    45.4%(v/v) 
Glacial acetic acid    9.2%(v/v) 
 
High Methanol solution   Low Methanol solution 
Methanol   45.4%(v/v)  Methanol   5%(v/v) 
Glacial acetic acid  7.5%(v/v)  Glacial acetic acid  7.5%(v/v) 
  
2.8.9. Preparation of dialysis tubes 
Dialysis tubes (MWCO 12000-14000) were cooked 10 min in 2% NaHCO3/1mM EDTA 
pH 8,0 and rinsed with dH20, and cooked 10 min in 1mM EDTA. Storage was in the same 
solution at 4°C and rinsed with H2O before use. 
 
2.8.9. In vivo labeling with [35S]-Methionine 
All centrifugation steps were at RT. 2x107 cells were centrifuged for 10 min at 2,000 rpm 
and washed with 500µl labeling medium by centrifugation at 6'000 g for 2 min. The cell 
pellet was resuspended in 400µl and 150 mCi of [35S]-Methionine (Amersham, in vivo 
labeling grade, 10 mCi/ml) was added. Cells were incubated for 1hr at 37°C (bloodstream) 
or 30°C (procyclics) and washed 2x with normal medium (6'000g for 2 min). Pellets were 
stored at –80°C until immunoprecipitation. 
 
 labeling medium 
ISCOVE’s medium (Gibco) lacking Methionine, supplemented with 10mM 
glucose, 1.5mM L-Cysteine (only for bloodstream), 0.14% β-mercaptoethanol 
(only for bloodstream), and 10% heat-inactivated FCS (previously dialysed against 
30mM HEPES pH 7.3 /150mM NaCl). 
 
2.8.10. Immunoprecipitation 
All centrifugation steps were at 4°C, 5 min at 13'000 rpm; incubations were also at 4°C. 
Each [35S]-Methionine-labeled sample, kept at –80°C as pellets, was solubilized with 
750µl solubilizing buffer, placed for 30 min on ice (vortexing every 5-7 min) and 
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centrifuged. The supernatant was put to rotate for 2 hrs or overnight with 40µl of 
Sepharose-protein A. After centrifugation, the supernatant was transferred to a new tube 
and incubated with the chosen antibody for 1 hr, also rotating, 40µl of Sepharose-protein A 
were added and centrifuged after 2 hrs. The Sepharose pellet was washed six times: three 
times with 500µl of buffer A, two times with 500ml of buffer B, and once with 500ml of 
buffer C. The last pellet was resuspended in 45ml of Lämmli buffer and denatured for 
SDS-PAGE; 15 ml (2x106 cells) were loaded in each lane. Following fixation with Low 
Methanol Solution, the gel was soaked in 5x gel volume EN3HANCE (NEN, PerkinElmer) 
for 1 hr under gentle agitation. The used enhancer solution was discarded into an 
appropriate radioactive waste container. The gel was soaked in cold water and agitated for 
45 min at 4°C, vacuum-dried (2 hrs at 80°C) and exposed to an X-ray film at –80°C. 
 
solubilizing buffer (10ml) 
50mM Tris-HCl pH 7.4 
500mM NaCl 
2% IGEPAL CA-630 (Sigma) 
1 tablet complete protease inhibitor (Roche) 
 
buffer A   buffer B   buffer C 
10mM Tris-HCl pH 7.5 10mM Tris-HCl pH 7.5 10mM Tris-HCl pH 7.5 
150mM NaCl   500mM NaCl 
0.2% IGEPAL CA-630 0.2% IGEPAL CA-630 
2mM EDTA   2mM EDTA 
 
Sepharose-protein A (Amersham Biosciences) 
0.5 g were hydrated for 1 hr in 200 ml of 100 mM Tris-HCl at 4°C and then washed with 
the same buffer. For storing, 0.02% Na-azide was added. Before use, the slurry was 
equilibrated in solution A. 
 
 
2.9. Isolation of polysomes and polysomal RNA 
Isolation of polysome were performed following a protocol adapted from (Djikeng, Shi et 
al. 2003). 
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2.9.1. Preparation of cytoplasmic extracts for polysomes 
Materials required:   -     Centrifuge tubes (SCI, 14x89mm Kat.-Nr.7030, Beckman) 
- Gradient maker (Gradient Master, Biocomp) 
- Leupeptin, 10mg/ml (Invitrogen) 
- Cycloheximide, 100mg/ml (dissolved in 100% EtOH) 
- Proteinase K, 20mg/ml 
 
All steps at 4°C. Cycloheximide was added (100µg/ml) to exponentially growing cells to 
freeze translating ribosomes on the mRNA. The drug was present in all buffers throughout 
the entire procedure. 5x108 – 2x109 cells were collected by centrifugation at 2000 x g for 5 
min and washed twice with ice-cold polysome buffer. Cells were resuspended in 0.5ml of 
polysome buffer and lysed by the addition of NP-40 (final 0.2%). The cell suspension was 
homogenized and the lysate was cleared by centrifugation at 10'000 x g for 4 min. 
 
2.9.2. Sucrose density gradient 
Gradients were prepared before cell extract preparation. Cleared lysate from 5x108 cells 
were layered onto 15%-50% sucrose gradients prepared in polysome buffer and 
centrifuged at 4°C for 2 hrs at 36'000 rpm in a Beckman SW41 rotor. Then 1-ml fractions 
were collected using the ISCO gradient fractionation system. The OD254 profile was 
recorded using the ISCO UA-6 detector. For protein sample preparations, the eluates were 
precipitated with 1ml of 20% TCA and protein pellets washed three times with acetone. 
For RNA extraction, each fraction was precipitated with 1ml of isopropanol, and the 
material was collected by centrifugation. Pellets were resuspended in 0.3ml  of a solution 
containing 10mM Tris-HCl (pH 7.5), 1mM EDTA, 100µg/ml proteinase-K, and 1% SDS 
and incubated at 65°C for 30 min. The sample was precipitated with 1 volume of 
isopropanol after addition of 20µg of glycogen and NaCl to 600mM. Samples were 
processed for Northern blot analysis as described in 2.6.2. 
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2.10. Indirect immunofluorescence assay (IFA) 
All steps were done at RT; washes were for 5 min, with gentle agitation. About 1x106 cells 
were centrifuged for 10 min at 2,000 rpm and resuspended in 4 mL of 1X PBS containing 
4% Paraformaldehyde. This parasite suspension was distributed in a four-chambered slide 
(Falcon) for fixation. After 25 min, the fixation solution was aspirated and the chambers 
washed with PBS. If the experiment had to be suspended at this point, the slides were kept 
at 40C with the cells immersed in PBS containing 0.2% sodium azide. On resumption, this 
buffer was discarded and the slides rinsed with PBS. Cells were then permeabilized by 
incubating in 0.2% Triton X-100 in PBS for 20 min. After washing, the cells were 
incubated in blocking solution (0.5% gelatin in PBS) for 20 min. Fixed, permeabilized 
cells were then incubated 1 hr in an appropriate dilution (1:500 to 1:1000) of the 
appropriate primary antibody in gelatin/PBS solution. The cells were washed twice with 
Triton X-100/PBS and incubated with the corresponding secondary antibody (anti-rabbit or 
anti-mouse IgG, Alexa-flour conjugated) in gelatin/PBS solution 30min. After two washes 
with 0.2% Triton X-100/PBS solution, the nucleic acids of the cells were stained for 10 
min with DAPI (4’, 6’-diamidino-2-phenylindole, 200ng/mL in PBS). The slides were 
washed once with PBS and air-dried. Controls were stained with antibodies or dyes 
individually to confirm that no fluorescence light was bleeding into the other channels. The 
chamber walls were peeled off and the slides mounted with a drop of 84% glycerol in PBS 
on each field.  Cells were examined with a Leica DM RXA microscope equipped with 
Deconvulsion Software Openlab (Improvision). Images were recorded using a Hamamatsu 
digital CCD camera (Hamamatsu Photonics K.K., Japan). Processing and pseudo-
colouring and merging of images were performed using Adobe Fotoshop software  
(version 7, Adobe Systems Incorporated). 
 
 
2.11. Tandem Affinity Purification (TAP) 
TAP purification was done as described in (Puig, Caspary et al. 2001) with minor 
modifications. 
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2.11.1. Preparation of cell lysate for TAP purification 
Reserve and pre-cool centrifuge and rotor SS34 and ultracentrifuge 75Ti, all other tools 
pre-cooled. For each TAP purification spin down 5x109 cells at 2000rpm at 4°C. Wash 
cells twice with 50ml ice-cold PBS. Snap freeze pellets in liquid Nitrogen and store at – 
80°C or directly proceed with extract preparation. Break cells in a final volume of 6ml 
breakage buffer (10mM Tris-Cl, 10mM NaCl, 0.1% IGEPAL, adjusted to pH 7.8 with 
HCl) including one tablet of complete inhibitor (without EDTA, Roche) by passing 15-20 
through a 21-25 gauge needle. Check on a glass slide to ensure complete breakage. Spin 
cell lysate at 10’000g for 15 min to remove cell debris. Transfer supernatant to pre-cooled 
Polycarbonate Thick Wall Beckman centrifuge tubes (13.5ml capacity, 355630 rec. No.). 
Spin at 35'000 rpm, 4°C, for 45 min. After centrifugation transfer supernatant to 15 ml 
Falcon. Measure volume and add NaCl to a final concentration of 0.14M (note that 
breakage buffer is already 0.01M NaCl). Mix and take 25µl aliquot (start material, #1). 
 
2.11.2. TAP purification 
200µl IgG sepharose bead suspension (Amersham Biosciences) is transferred into a 0.8x4-
cm Poly-Prep column (Bio-Rad) and washed with 10ml IPP150 (10mM Tris-cl, pH 7.8, 
150mM NaCl, 0.1% IGEPAL). The cleared cell lysate is adjusted to 10mM Tris-Cl, pH 
7.8, 150mM Nacl, and 0.1% IGEPAL) and tranferred into the column containing the 
washed beads and rotated for 2hrs at 4°C. Elution is done by gravity flow. 25µl of 
flowthrough (IgG flowthrough, #2) is taken for subsequent analysis. The beads are washed 
three tiems in 10ml of IPP150 and once with 10ml of TEV cleavage buffer (IPP150 
adjusted to 0.5mM EDTA and 1mM DTT). Cleavage is done in the same column by 
adding 1ml of TEV cleavage buffer and 100 units of TEV protease (Gibco). The beads are 
rotated for 2hrs at 16°C and the eluate is recovered by gravity flow. Take 15µl aliquot (IgG 
eluate, #3). 
200µl of calmodulin affinity bead suspension is transferred to a column and washed three 
times with 10ml of IPP150 calmodulin binding buffer (10mM Tris-Cl, pH 7.8, 10mM β-
mercaptoethanol, 150mM NaCl, 1mM magnesium acetate, 1mM imidazole, 2mM CaCl2, 
0.1% IGEPAL). Three mililiters of IPP150 calmodulin binding buffer and 3 µl of 1M 
CaCl2 are added to the 1 ml of eluate recovered after TEV cleavage. This solution is 
transferred to the column containing washed calmodulin beads and rotated for 1 h at 4°C. 
Beads are washed three times with IPP150 calmoduling binding buffer. The bound proteins 
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are eluted with 1 ml of IPP150 calmodulin elution buffer (10mM Tris-Cl, pH 7.8, 10mM 
β-mercaptoethanol, 150mM NaCl, 1mM magnesium acetate, 1mM imidazole, 2mM CaCl2, 
0.1% IGEPAL, 2mM EGTA). The eluate is concentrated by TCA precipitation. 
 
2.11.3. TAP purification to isolate mRNP complexes 
The TAP purification method was also used to isolate mRNP complexes. The protocol of 
(Gerber, Herschlag et al. 2004) was adapted. To this end, 1x109 cells expressing the TAP-
tagged protein of interest were lysed in 6 ml breakage buffer (see 2.10.1.), supplemented 
with 200 units RNaseIn (Promega) and 5µl Vanadyl Ribonucleoside complexes (Sigma). 
Binding, washing, and TEV cleavage were done as described in 2.10.1., but TEV cleavage 
buffer was supplemented with 200 units RNaseIn and 5µl Vanadyl Ribonucleoside 
complexes. The eluate after the TEV cleavage was supplemented with 0.1% SDS and 30 
µg proteinase K, and incubated for 30 min in a 55°C water bath. The immunoprecipitated 
RNA was isolated by phenol-chloroform-isoamyl alcohol extraction and ethanol 
precitpitation. Note, that mRNP complexes can be isolated from all cells which express 
epitope-tagged mRNA binding proteins using immunoprecipitation (see, (Tenenbaum, 
Carson et al. 2000; Tenenbaum, Lager et al. 2002). Negative controls were applied either 
by using cell lines expressing only the TAP-tag or using cell lines expressing an untagged 
version of the mRNA binding protein of interest. 
 
2.12. Tethered-functional analysis 
The tethered-functional analysis is based on RNA-protein interaction. The binding of the 
RNA-binding domain of the λ phage antiterminator protein N (referred to here as λN) to a 
specific λ-N binding site (boxB) in an mRNA containing this boxB was used in this study 
(Fig.2.2.). An asset of this approach is that analysis of function is independent of 
knowledge of the natural RNA target. To this end, a chimeric protein consisting of λN 
linked to TbPUF1 (or TbPUF9) was expressed in T. brucei procyclic cells; the same strain 
also carried a second plasmid expressing the CAT reporter mRNA with six λN recognition 
sites in its 3’-UTR. 
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Fig.2.2. Tethered function assays using the 3’-UTR. PUF (P) is brought to the CAT reporter mRNA through 
binding of λN to the boxB in the 3’-UTR. The function of the tethered PUF protein in any aspect of the 
mRNA’s metabolism or function can be assayed. 
 
 
2.13. Microarray 
Microarray analysis was performed as described in (Diehl, Diehl et al. 2002) with some 
modifications. 
 
2.13.1. Genomic T. brucei microarray 
Genomic T. brucei microarrays were generated by Stefanie Brems at the DKFZ (Deutsches 
Krebsforschungszentrum, Heidelberg, Germany). In brief, 24,567 random shotgun clones 
representing the genome of T. brucei brucei strain TREU927/4 were provided by Najib El-
Sayed of the Institute for Genomic Research (TIGR, Rockville, USA). These clones were 
PCR amplified in 384- or 96-well microtiter plates using primers 
d(TTGTAAAACGACGGCCAGTG) and d(GCGGATAACAATTTCACACAGGA), 
which are flanking the multiple cloning site of vector pUC18. The PCR products were 
checked by agarose gel electrophoresis. 
 
DNA fragments were spotted onto poly-L-lysine coated glass slides as described in (Diehl, 
Grahlmann et al. 2001). Spotting was done with an SDDC-2 DNA Micro-Arrayer from 
poly(A) CAT 
poly(A) CAT 
boxB 
boxB 
λN 
P
λN
P
?
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Engineering Services Inc. (Toronto, Canada) and SMP-3 pins (TeleChem International 
Inc., Sunnyvale, USA). Subsequently, the slides were cross-linked using UVC-500 (Hoefer 
Scientific Instruments, San Francisco, USA). 
 
2.13.2. Sample preparation, labeling and hybridisation 
Total RNA from 4x108 exponentially growing cells (below 1x106 cells/ml for bloodstream 
forms and 2x106 cells/ml for procyclics) was isolated using Qiagen RNeasy Midi Kit. 15µg 
of total RNA was reverse transcribed using SuperScriptTM III (Invitrogen). The following 
protocol for a 40-µl reaction volume was used: 
 
1. Add the following components to a nuclease-free microcentrifuge tube: 
5µl  of oligo(dT)12-18 (100ng/µl) (500ng) 
15µg   of total RNA 
3µl  dAGT-mix (10mM) 
2µl  dCTP (1mM) 
2µl  Cy3/Cy5-dCTP (1mM) 
RNase free water to 27µl 
2. Heat mixture to 65°C for 5 min. and incubate on ice for at least 1 min. 
3. Collect the contents of tube by brief centrifugation and add: 
  8µl   5x First-Strand Buffer 
  2µl   0.1 M DTT 
  1µl  RNAseInTM  (Promega) 
  2µl  SuperScriptTM III RT (200 units/µl) 
4. Mix by pipetting gently up and down. If using random primers, inc. 
 tube at 25°C for 5 min. 
5. Incubate in the dark at 50°C for at least 3hrs (or overnight). 
6. Inactivate the reaction by heating at 70°C for 15 min. 
7. Add 1µl RNaseH (Roche). 
8. Incubate 20 min. at 37°C. 
9. Use QIAquick PCR Purification Kit (QIAGEN, Hilden, Germany). 
10. Elute cDNA with 2 x 50µl RNase free water. 
11. Measure cDNA concentration. 
12. Ethanol-precipitate cDNA. 
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13. Resuspend cDNA-pellet in 5µl TE, vortex. 
 
Prehybridisation/Hybridisation: 
14. Wash DNA chip 10 sec. in 0.2% SDS, 10 sec. in dH20, and 3 min in 95°C 
dH20. 
15. Place slide into Atlas Glass Hybridization chamber (DNA-Array side up!) 
and fill with 2ml Prehybridization Buffer (5x SSC, 0.1% SDS, 1% BSA) 
16. Incubate for 45 min at 55°C. 
17. Wash the slide by dipping 3x in dH20 at RT. 
18. Dip the slide in Isopropanol (abs.) and dry. Slides should be used 
immediately after prehybrization. 
19. Mix Cy3- and the corresponding Cy5-labelled cDNA and denature at 95°C 
for 5 min. Immediately put sample on ice. Quickspin. 
20. Add 60µl of hybridisation buffer (50% formamide, 3x SSC, 1% SDS, 5x 
Denhardt’s reagent and 5% dextran sulfate). 
21. Spread hybridisation mix over glass slide. Cover with cover slip, and 
hybridize o/n in a dark humidified chamber at 62°C. 
22. Wash the slides at  RT: 10 min in Washing Buffer 1 (2x SSC, 0.2% SDS), 
10 min Washing Buffer 2 (2x SSC), and 10 min in Washing Buffer 3 (0,2x 
SSC). Dip the slide in Isopropanol (abs.) and dry. 
 
2.13.3. Image acquisition and data analysis 
DNA chips were scanned with ScanArray 5000 (Packard BioScience, Dreieich, Germany) 
subsequently with Cy3- and Cy5-channel at a resolution of 10µm. Analysis of resulting 
image were performed using GenePix software (Axon Instruments, Union City, USA) to 
generate numerical values of spot signal intensities. The software package MCHIPS  
(Fellenberg, Hauser et al. 2001) was used for data quality assessment and normalisation. 
Differentially regulated transcripts were confirmed by Northern blot analyses. 
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2.14. Ettan DIGE system (Amersham Biosciences) 
The DIGE work was performed under the supervision of Richard Burchmore at the Sir 
Henry Wellcome Functional Genomics Facility in the Institute of Biomedical and Life 
Sciences (IBLS) at the University of Glasgow, Scotland. 
 
EttanTM DIGE system is based on the technique of two-dimensional difference gel 
electrophoreis (2-D DIGE). In this approach, protein samples are labeled with up to three 
spectrally distinct, mass and charge matched, fluorescent dyes (Cy2, Cy3, and Cy5). 
Labeled proteins are then mixed and resolved simultaneously on the same 2-D gel 
(Fig.2.3.). Sample multiplexing greatly defines the detection of changes between samples 
at the protein level. Spot maps can be overlaid and compared directly for samples resolved 
on the same 2-D gel. In addition, variation in spot intensities due to experimental factors 
will be the same for each sample on the 2-D gel. Thus the relative concentrations of the 
samples in a gel will be effectively unchanged. This increases the confidence with which 
protein differences (due to changes in protein expression) can be both detected and 
quantified using Ettan DIGE system. Following protocol is optimized for T. brucei sample 
preparation. For a more detailed description of the system refer to Ettan DIGE System 
User Manual 18-1173-17 Edition AA. 
 
Fig.2.3. Outline of Ettan DIGE system. Work in this thesis was performed using only two labels (Cy3 and 
Cy5). Figure is taken from Ettan DIGE System User Manual 18-1173-17 Edition AA. 
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2.14.1. Protein sample preparation for DIGE 
For each sample ~2x108 cells were collected at 2000 rpm at 4°C for 10 min and washed 
twice with cold PBS. Cell pellet was lysed in 500ml DIGE lysis buffer (7M urea, 2M 
thiourea, 4% CHAPS, 25mM Tris-base pH 8.5) and cell lysate was cleared twice at 
13’000rpm at 4°C for 10 min. The protein concentration of the supernatant was measured 
using BRADFORD assay (2.8.2.). One volume of ice-cold 20% TCA is added and 
incubation was done on ice for 30 min (or overnight). Protein was pelleted at 13’000 rpm 
for 10 min 4°C. The supernatant was discarded and pellet washed three times with cold 
acetone. After drying for 10 min at RT the pellet was dissolved in DIGE lysis buffer at 
protein concentration >5mg/ml. Adjust pH to 8.5. Note, protein pellet is somewhat difficult 
to dissolve. Vortexing, grinding and passing through a 21-25 gauge needle might be 
necessary. Protein sample was adjusted to a concentration of 5mg/ml and aliquoted in 
10µl. 
 
2.14.2. CyDye labeling of protein samples  
On ice, 400 pmol CyDye was added to the 10ml, mixed immediately by pipette strokes and 
incubated on ice for 30 min in the dark. One microliter of 10mM lysine was added to stop 
the reaction. Labeled samples can be stored at –80°C until use. The Cy3 and Cy5-labeled 
proteins samples were mixed and 40µl of each unlabelled protein sample (5mg/ml) was 
added to give a final volume of 102µl. 
 
2.14.3. Running the first dimension 
370µl of rehydration buffer was added to the 102µl and mixed by a brief vortex. The 
Immobiline DryStrips were rehydrated in the Immobiline DryStrip Reswelling Tray in the 
presence of the 450µl protein sample. The protein samples were then focused on the Ettan 
IPGphor IEF unit with following settings: 
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Immobiline DryStrip Rehydration loading 
Length pH range Step and voltage 
mode 
Voltage 
(V) 
Step duration 
(h:min) 
Volt-hours 
(kVh) 
24 cm 3-10 NL 1 Step and Hold 500 1:00 0.5 
  2 Step and Hold 1 000 1:00 1.0 
  3 Step and Hold 8 000 8:20 62.5 
  Total  10:20 64 
 
 
2.14.4. Equilibration and running second dimension 
After isoelectrifocusing the IPG strips were placed in individual tubes and equilibrated 15 
min in 10ml SDS equilibration solution supplemented with 100mg DTT and then 15 min in 
10ml of the same buffer without DTT but with 250mg iodacetamide with gentle agitation. 
The strip was placed on to a 12.5% SDS gel and run until the bromphenolblue has left the 
bottom. 
 
2.14.5. Scanning and Image acquisition 
The gel was scanned subsequently with the Cy3- and Cy5-channel at 100 microns 
resolution using a Typhoon Imaging scanner 9400 (Amersham Biosciences). 
Representative spots were picked for normalisation over the two channels using Typhoon 
Scanner Control Software, version 3.0 and ImageQuant Tools software, version 3.0. 
 
2.14.6. DeCyder Differential Analysis Software 
DeCyder Differential Analysis Software is a fully automated image analysis software suite 
for detection, quantitiation, positional matching and differential protein abundance 
analysis. A description of the algorithms and workflow would go beyond the scope of this 
thesis. The reader is referred to the DeCyder Differential Analysis User Manual 18-1173-
16 Edition AA. 
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3. Results 
The experimental goal of this thesis was to look for PUF proteins in Trypanosoma brucei, 
to characterize them, and to analyze their role in global transcript modulation and 
translational control. This was done using a combination of transcriptomics (microarray 
analysis) and proteomics (two-dimensional gel electrophoresis) approaches. Furthermore, 
attempts to look for PUF interaction partners were undertaken. 
  
3.1. T. brucei has ten members of the PUF protein family 
 
Since most organisms in which PUF proteins have been characterized have multiple PUF 
members, I tried to determine whether this was also true for T. brucei. With the recent 
completion of the T. brucei genome (Berriman, Ghedin et al. 2005) and the help of 
database mining the presence of nine additional PUF proteins in T. brucei became apparent 
(Fig.3.1.). All ten T. brucei PUF proteins bear at least four of the eight characteristic Puf 
repeats. Some PUF repeat sequences are somewhat divergent from the consensus, for 
example in TbPUF5, and are therefore not recognised by Pfam model (Pfam accession 
number PF00806). The high number of PUF protein family members in T. brucei is 
consistent with the observation that more primitive organisms, including C. elegans and S. 
cerevisiae possess multiple PUF proteins, whereas only one PUF protein (with two 
isoforms) is present in Drosophila. Vertebrates also appear to have a smaller number of 
PUF proteins - humans and mice each have two (Barker, Wang et al. 1992; Zamore, 
Williamson et al. 1997; Zhang, Gallegos et al. 1997; Wickens, Bernstein et al. 2002). 
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Fig.3.1. Schematic representation of the ten PUF genes in Trypanosoma brucei. Orange boxes show Pfam 
PF00806 Pumilio-family RNA binding repeats. Pfam model does not necessarily recognize all eight repeats 
in all sequences; some sequences appear to have only 4 or 5 repeats on initial analysis, but further analysis 
suggests the presence of additional divergent repeats.  Puf repeats together form the Pumilio homology 
domain (PUM-HD), which is predominantly located in the middle or at the C-terminus of the protein. The N- 
terminus of the TbPUF proteins is more divergent. Diagrams are taken from the homepage 
www.genedb.org/genedb/tryp, and TbPUFs are identified by their TIGR Genome Annotation Database 
(TGAD) number. 
 
In overall organization, as is true for other PUF proteins, the Puf repeats of TbPUFs are 
located in the middle or near the C-terminus of the protein; typically the N-terminal 
regions are more divergent. The smaller PUF proteins in T. brucei (e.g. TbPUF5) appear to 
consist of only the PUF domain. Since this domain is necessary but also sufficient to exert 
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the proteins functions, it is expected, that T. brucei PUF proteins are indeed functional. 
Except for the conserved PUF domains, the TbPUF proteins differ considerably. For 
example TbPUF4 is a relatively large protein with 988 amino acids and a predicted 
molecular weight of 106.4 kDa, whereas TbPUF5 has only 430 residues and a predicted 
molecular mass of 46.6 kDa. The calculated pI of TbPUFs range from pH 6.1 (TbPUF1) to 
basic pH 10.4. (TbPUF8). With the exception of a predicted transmembrane helix in 
TbPUF3 and a putative mitochondrial localization signal in TbPUF5 none of the TbPUFs 
bears a targeting signal. 
 
The TbPUF genes are located on chromosome 1, 3, 6, 7 and 10. Interestingly, the genes 
share high conservation of synteny between the T. brucei, T. cruzi, and L. major (referred 
to here as the “Tritryps”). For example the downstream gene of PUF9 in all three 
pathogens codes for an exosome associated protein EAP1, which is an Rrp42 homologue 
similar to RNasePH proteins in bacteria. The upstream gene of PUF7 in the Tritryps 
genome codes for a zinc finger protein 2. TbPUF1 is a single copy-gene (Hoek, Zanders et 
al. 2002). To investigate the copy number of TbPUF9 Southern blot analysis was 
performed. This analysis indicated that TPUF9 is also a single copy gene (Fig.3.2.). It 
should be noted, that the strains used in our laboratory are different from the strain 
sequenced in the course of the genome project. Southern blot analyses have not been done 
for the other TbPUF genes. 
 
 
 
PUF proteins contain eight consecutive repeats of ∼40 amino acids, called Puf repeats. 
Each Puf repeat contains a diagnostic central consensus sequence (Zamore, Williamson et 
al. 1997; Zhang, Gallegos et al. 1997). When the eight Puf repeats of the ten TbPUF 
Fig.3.2. TbPUF9 is a single copy gene. Southern blot analysis 
with 10µg of genomic DNA from T. brucei 427 pc cut with 
indicated restriction enzymes and hybridzed with a 32P labeled 
probe recognizing TbPUF9. 
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proteins were aligned with those of the Drosophila Pumilio protein, the highest 
conservation can be seen in regions corresponding to the core consensus sequences 
(Barker, Wang et al. 1992; Macdonald 1992) (Fig.3.3.). The flanking regions around the 
trypanosome Puf repeats are also shorter compared with other family members. The RNA-
binding domain of TbPUF6 is most similar to that of Pumilio (45% identity) whereas 
TbPUF8 Puf-domain only shares 24% identity with that of Pumilio. The conserved 
aromatic and basic amino acids in the core consensus confer base stacking and backbone 
interactions with RNA (Edwards, Pyle et al. 2001; Wang, Zamore et al. 2001; Wang, 
McLachlan et al. 2002; Edwards, Wilkinson et al. 2003). The conservation of the repeats of 
the Puf domain suggests that TbPUFs share a similar 3-dimensional structure and possess 
similar RNA binding activity. On the other hand the divergence between the Puf domains 
within TbPUFs may imply that they bind related but distinct mRNA targets and have 
different roles during parasite development. 
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~~~~~~~~~~EFRLQVVSLCKD......QDGSR..CVQRLLN.....NPENIEPIFNEVFPR.THELIID...VFGNYVLQKLLDM 
~~~~~~~~~~NLRGNVYELAKD......QHGCR..FLQRLLCDPEA.DCEIPRTIMSEIVPH.VAELMTD...QYANFLVQKLFDI 
~~~~~~~~~~LHGGRIVKLAAD......QQGCR..MLQSVLERFPF.HSSEVQKVISELLPV.LTDVMKD...PYGNFLVQKLLEV 
~~~~~~~DNDGADPVCVSGSGDG....NCEAPRHVYNSAVLDS.GN.LSNGLVERFRAIVGE.LPRAACT...SAGRNLLVSVLRL 
~~~~~~~~~~HILNHAVEFAQD......QEGSR..FIQRAVES..A.THDEVDALFREIFES.PLELVVD...VFGNYVLQKLLEV 
LDKCDGLIRVQVLYQLRRKLVDLS....RSNVGNIIVREMLEKLPAKQKKEIAEVFVLNAEEDEFKRLCT..HRIGNYVAQKIIEY 
~~~~~~~~~~KIEPKFDTYVRT......PRTSR..VIQSMIKYG...STEQLGKIVGLISSG.YANYATD...AYGHFVVVALLRH 
~~~~~~~LYAQPRPSQQPPPSQ.....APIYSKAVTAPTALDVH.P.LIDTTSEFLRKCAGR.VVELACT...PDGRSMLINALSS 
NQPYPNLQLRDLANHIVEFSQD......QHGSR..FIQQKLER..A.TAAEKQMVFSEILAA.AYSLMTD...VFGNYVIQKFFEF 
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SESDLSEFLLLLEVLKDKIPQICCDTNGSRAMQKVFDSLKSL.EEVEFSAQCFSECIIELCKDIDGN.HAVSRLLAA 
 LPTESDMCKRLIKQVSGRLKEYSFQMYGCRVIQKMLEKASP..EKREEVLFELKDCLVECIFDQNAN.HVAQKLIEV 
MPKD..VRYSVACVAAPKIAAIALTPHGTFSVQKMIETISSR.EELVIIREALSKDVVRLVKDANGN.HAIQKVLQL 
 APDE.ERMRLLDYHISASLCDVAISPHGNYAVQKLIDSLRSS.QEVQVVCRALQRGTLQLMTDLNGG.HVIQKLLQC 
HHVE..MTRTVVDEFRPVLPAVALDSNGCHVVRALVEFIPTG.LMATLVPHFTPSLVRDLAVSSPYTRRVLQSVFER 
GNAR..QLAYAATRLQNNVVNLTLQTYGCRVIQKCIEVMPP..EGLDIILSELRGNVAKCIQDQNGN.HVVQKCVEV 
PSSC....EVVEERFLPYLGQLALHEFGQRVVAKYVGVTSDG.WKQVCKALFGLDDDVTLKKGKTGDDTLQERISQV 
APHD..LFDKILSLTIPAVPTLISHRFGIEVIHSAYSSNLCTATNRNLLILAVFKDNIALMKRWKGY.PILEDVLAQ 
QDAA..LVDTMVREIADDLERVALDVHGCHVLRALQSYASAE.HTRILVSCFTETLVLNLCTATQHTRHILESLFQR 
 GTPE..QKNTLGMQVKGHVLQLALQMYGCRVIQKALESISP..EQQQEIVHELDGHVLKCVKDQNGN.HVVQKCIEC
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ARGTPLWESGAAGDDSSSKLAHIHQLLYGKFPESCVDVCGNRHG....CCVIQKCLQWAPE....PYFSTLMDTIVHDTIKLVHDP.FGNYVIQFILDH 
I...PEKT................QLLVDSFMPHLKALSRHPYG....CRVLQCVFERCSTA.HGVNIRPMLEAVLENVHEYVMDQ.YGNYVVQYALLN 
FE..PDDK................EFVYAAVAVDCITIAKNKQG....CCVLQRCLEYASP....AQRSTLVRHILECCLQIAEDP.YGNYVLQYVISA 
IS..PKDL................TFLYDVIVKDTVDVCNDKHG....CCVVQKCMDHAIN....VHLQRTQKAILRHMLQLSLNP.YGNYVVTHLISM 
HK..SDAL................TPIVEAIAQDSQLLAQRQQG....CITIIRTIENTLP....HQQRFIISRLLPALPALTMNC.YGNYVVQCVLHH 
I...PQRC................GFIVSAFSGRVMELATHAYG....CRVIQCIMDHCP.....DQEEAIFSELLDCVGTLATDQ.YGNYVIQHVLQH 
IKTTNDNMTLSALLKHP....LVPSRVKDALCAHLSEYAGEYLNPQSVCTGAQKGEKVAEDD...EFAAPEFGDLPLTKASRGHDQXYGDFAQRKELWD 
EV..EQR.................KRLLPKLFELCEKLVSQKSAVD..FPFVQRLAAAFIRNGTKHEVSELCDTLRPHLAVLCTIR.EGAPLASLAFSL 
R...LIDL................QPIIDVLASHSRYLAATQQG....CISFMHILEFCNE....AQKKQLISPLVPYFAHVALDP.FGNYVVQRIIQS 
VD..PVAL................QFIINAFKGQVYSLSTHPYG....CRVIQRILEHCTA....EQTTPILDELHEHTEQLIQDQ.YGNYVIQHVLEH
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EQELSQRSSTGSEGADYTNRIIRQMLHNVAAL..SC....NKFCSNVIEKCLKSAT..PDVRQLLVDELTDPQ.............ILPKLLTDSFANYVIQTAIVT 
AP...EELRQ.........RFVTQLIPHVYAL..SC....SKFASNVAEKTIIKAN..AEELQQVVETLTHPLG......ASEDGNYLVLMMQDQYANYVVQRLLQQ 
GD...SKTID.........TIAIAFLPHLVQL..CM....NKFSSNVMEKVLCRVS..PLVQEMYVDTMCTPE.............VAARLIQDDFGNYVLQTALTI 
QCNSSQRHVVN........EAAHCAGPALELL..CA....NKFASNVVEKIVQGCA..PSAKLELCRFLFNRST......IN.TGMSARLMGMDYVLGEQDPQQRLM 
MD...PEAVT........VVVCHAFAGHWVAL..SC....NKFASNVVEKVVRVLEG.PARRALIAETVCDPV.............NLRRLMNDCFGNFVLQAIIDS 
MK...DDEKVG........RIFDALKGNFYES..SK....QKFASNVMEKLFVRAD..PQQRMELVNMMCSPIG..........DDSGEPVEVLSFKRSSAPKKENV 
CIVAAPGLVDHIVS...HKFVINVAVAAFKSYPESQDALWNALVGNEGRDVVEVSQD.PVGTMLLRAAMEVDNKRFTAAHRRHLAESTLTLSQDPVSSPVIQKLLEC 
.TE..PKKRK.........VILRAFSENLGVL..VV....SKYSAPVIARLFDIVY...DVQLLCKYVVNDVVS............HITQLINSPFGHQILLHLLTP 
IG...LDASE.........YITSCFAGELLNM..SC....NKFGSNVVEETIKVCGGVPAVRRLLMEELISKPG............ALQRLVQDSFGNFVVQTFIGS 
GK...QEDKS.........ILINSVRGKVLVL..SQ....HKFASNVVEKCVTHAT..RGERTGLIDEVCTFN...........DNALHVMMKDQYANYVVQKMIDV
 
Fig.3.3. ClustalW alignment of the Puf domains of the nine TbPUFs and Drosophila Pumilio. Eight 
imperfect Puf repeats are indicated. Conserved residues (at least 6 out of 10 cases) are colored black. Less 
conserved amino acids are highlighted grey (at least 4 out of 10). Dots (.) are introduced to optimize 
alignment. 
 
 
 
To investigate the conservation of PUF proteins among Trypanosoma brucei, 
Trypanosoma cruzi and Leishmania major, each TbPUF protein sequence was used to blast 
against the database of T. cruzi and L. major using the BlastP algorithm 
(www.genedb.org/genedb/tryp/blast.jsp). Interestingly, each PUF protein has an orthologue 
in all three pathogens (Fig.3.4.). Highest homology exists within the PUF8 group with 62% 
and 52% identity between TbPUF8 and TcPUF8, and TbPUF8 and LmPUF8, respectively. 
Repeat 2 Repeat 1
Repeat 3 Repeat 4 
Repeat 5 Repeat 6 
Repeat 7 Repeat 8 
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To investigate the distribution of Tritryp PUF proteins among eukaryotes a phylogenetic 
tree was generated using only the PUF domains from 93 Puf members (Fig.3.5.). 
 
 
Fig.3.4. Conservation of PUF proteins among kinetoplastids. A phylogenetic tree was derived by aligning the 
amino acid sequences of the PUF proteins of Trypanosoma brucei (Tb), Trypanosoma cruzi (Tc), and 
Leishmania major (Lm) with Clustal W.  Each member of the PUF family has an orthologue in the three 
species. 
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Fig.3.5. PUF proteins troughout eukaryotes. A phylogenetic tree was derived by aligning only the PUF 
domains from 93 Puf members. Af, Aspergillus fumigatus; Ag, Ashbya gossypii; Am, Apis mellifera; At, 
Arabidopsis thaliana; Bt, Bos taurus; Ce, Caenorhabditis elegans; Cf, Canis familiaris; Dd, Dictyostelium 
discoideum; Dj, Dugesia Japonica; Dm, Drosophila melanogaster; Hs, Homo sapiens; Hv, Hordeum 
vulgare; Lm, Leishmania major; Mm, Mus musculus; Nc, Neurospora crassa; Os, Oryza sativa; Pf, 
Plasmodium falciparum; Pp, Physcomitrella patens; Pt, Populus tremula x Populus tremuloides; Rn, Ratus 
norvegicus; Sc, Saccharomyces cerevisiae; Sp, Schizosachharomyces pombe; Spu, Strongylocentrotus 
purpuratus; Tb, Trypanosoma brucei; Tc, Trypanosoma cruzi; Xl, Xenopus laevis.  GenBank accession 
numbers identify each entry. 
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Some clustering can be observed when looking at the phylogenetic tree representing the 
distribution of 90 Puf members. PUF proteins of vertebrates (yellow) seem to form a 
subfamily, and they are closest related to PUF members of dipterans (blue). In contrast to a 
previous phylogenetic analysis using only 34 Puf domain amino acid sequences (Cui, Fan 
et al. 2002) no obvious separation between plant and animal PUF members can be drawn. 
Interestingly, kinetoplastid PUF members are spread throughout the eukaryotic lineage, as 
is true for yeast PUF proteins. A hypothesis, based on this observation, is that PUF proteins 
lost their diversity in the course of evolution. 
 
3.2. Depletion of PUF proteins or their RNAs does not affect 
growth of Trypanosoma brucei in vitro 
 
3.2.1. RNA interference of each PUF protein in Trypanosoma brucei 
The use of double-stranded RNA (dsRNA) to disrupt gene expression has become a 
powerful method in a wide variety of organisms ranging from Kinetoplastida, fungi, green 
plants, planaria, dipterans, teleosts to most recently mammals, including humans (Cogoni 
and Macino 2000). This tool, called RNA interference (or RNAi), has become the method 
of choice to study gene function in T. brucei. As has been shown in multicellular 
organisms, the RNAi mechanism in T. brucei involves processing of double-stranded RNA 
to 24- to 26-nt RNAs, termed small interfering RNAs (siRNAs), which guide degradation 
of the target mRNA (LaCount, Bruse et al. 2000; Shi, Djikeng et al. 2000; Wang, Morris et 
al. 2000; Inoue, Otsu et al. 2002). Very recently it was demonstrated that chemically as 
well as enzymatically synthesized siRNAs are also functional in the parasite (Best, 
Handoko et al. 2005). 
 
To investigate the role of PUF proteins in T. brucei, RNAi knockdown was performed for 
each PUF protein in bloodstream and procyclic cells. To ensure high specificity of RNAi 
knockdown we used a software tool (RNAit, (Redmond, Vadivelu et al. 2003) for the 
selection of RNAi targets. Figure (Fig.3.6.) shows the RNAi-targets of the TbPUFs. 
Primers are selected utilising the MIT’s primer3 program  
(http://wwwgenome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi) and NCBI blast 
(http://www.ncbi.nlm.nih.gov/BLAST/). This combination allows theoretical PCR 
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products to be checked against the available T. brucei genome sequence. Only those with 
sufficiently low homology to the rest of the genome are selected. Therefore unspecific 
knockdown of more than one PUF gene is not expected, despite the fact that nearly all 
regions for RNAi lie within the PUF-domain (Fig.3.6). 
 
 
Fig.3.6. Primers used to amplify the region of RNAi-target within the open reading frame. A combination of 
the MIT's primer3 program and NCBI blast was used to select suitable primers and to minimise off-target 
knockdown. With the exception of TbPUF1, all regions for RNAi lie within the PUF-domain. 
 
TbPUF-RNAi PCR products were cloned between two opposing T7 promoters in p2T7-
177 (LaCount, Bruse et al. 2000) (PUF1,3,4, and 9) or in p2T7TA-blue (Clayton, 
Esteacutevez et al. 2005) (PUF2,5,6,7, and 8). The resulting TbPUF-RNAi plasmids were 
transfected into T. brucei 427 1313 514 bloodstream (bf) and procyclics (pc) cell lines. 
After selection with hygromycin, RNAi was induced by the addition of tetracycline and 
total RNA was prepared after 48 hours. To check depletion of TbPUF transcripts Northern 
blot analyses were performed. As can be seen in Fig.3.7. the transcripts were down-
regulated by the addition of tetracycline. RNAi efficiency ranged from 82% (TbPUF3) to 
only 25% (TbPUF6) knockdown. Increasing the tetracycline concentration did not lead to 
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higher RNAi efficiency (data not shown). TbPUF1 transcript downregulation was most 
efficient already 24 hrs after induction for bf and pc cells (Fig.3.9). Knockdown of 
TbPUF1 was also verified by Western blot analysis (Fig.3.9). However, TbPUF1 protein 
levels (compared to transcript levels) seemed to be totally unaffected in procyclic cells as 
shown by Western blot analysis. RNAi induced cells were grown in the presence of 
tetraycline for five days and growth was monitored every 24 hours (Fig.3.8.). Silencing of 
TbPUFs did not affect growth of bloodstream or procyclic cells. 
 
 
 
 
 
 
                                                        
Fig.3.7. A) Northern blot showing downregulation of 
TbPUF transcripts. Equal amounts of RNA (10µg) 
from RNAi uninduced (-) and induced (+) 
bloodstream (bs) and procyclics (pc) cells were loaded 
on each lane. After probing for TbPUF transcripts, the 
same filter was hybridized with srp (signal recognition 
particle) serving as a loading control. TbPUF 
transcript sizes are indicated. B) Western blot of E. 
coli expresssing TbPUF1 (MH227, (Hoek, Zanders et 
al. 2002) using α-TbPUF1. Expression was induced 
by the addition of IPTG. C) Western blot using α-
TbPUF1 to assess PUF1 protein expression level in 
wild-type procyclic (pc) and bloodstream form (bf) 
cells, as well as in TbPUF1 RNAi (1538) uninduced  
(-) and induced (+) cell lines. Cytosolic marker (CSM) 
was used to assess for loading variation. 
A 
C 
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Fig.3.8. Effects of depletion of single TbPUFs on 
cell growth. RNAi bloodstream form cell lines 
were grown in the absence (-) or presence (+) of 
tetracycline and growth monitored for 5 days. 
Cells were diluted all 24 hours to a density of 
1x105 cells/ml. Similar results were obtained for 
RNAi procyclic form cell lines (data not shown). 
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3.2.2. Knockout of Tbpuf1 
Double-stranded RNA based gene silencing of TbPUF1 did not result in a growth 
phenotype for bloodstream and procyclic cells. It is possible that downregulation by RNAi 
was not sufficient and that residual (∼20% in bf and ∼25% in pc) TbPUF1 is still able to 
exert its physiological function. To check this, a TbPUF1 knockout was performed in 
procyclic cells using classical homologous recombination as described in the Materials & 
Methods section. Southern, Northern and Western blot analyses showed that TbPUF1 was 
successfully knocked out (Fig.3.10.). Surprisingly, deletion of the TbPUF1 gene was not 
lethal for procyclic cells. This contradicts the results of (Hoek, Zanders et al. 2002) who 
claimed, based on a failure to delete the gene, that TbPUF1 was an essential gene in T. 
brucei procyclic and bloodstream forms. 
Fig.3.9. Northern and Western blot analysis 
to assess TbPUF1 RNAi efficiency for a  
prolonged time of incubation for bf (a) and 
pc cells (b). 
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Fig.3.10. Deletion of TbPUF1 in procyclic cells. Southern (a), Northern (b), and Western (c) blot confirming 
TbPUF1 deletion. a) 10µg of genomic DNA were cut with BamH1 and loaded onto each lane. A probe for 
PUF1 (recognizing bp 206-692 of PUF1-cds) was labeled with 32P. Ethidium bromide staining of gel serves 
as loading control. b) 10µg of total RNA was loaded onto each lane. Probes are for puf1, neomycin (neo), 
blasticidin (bsd), and SRP transcript. c) 3x106 cells were loaded on to each lane, and the blot was probed with 
α-TbPUF1 antibody. 
 
3.2.3. RNAi double knockdown of PUF proteins 
Since T. brucei possesses multiple PUF proteins, it is possible that they share redundant 
functions. To assess the question which PUF-pairs would be most likely to have redundant 
functions, a phylogenetic tree using only the TbPUF-domains was generated. PUF1, PUF3, 
and PUF4 together form a branch. Within the Puf repeats, the amino acid sequence of 
PUF1 is 33% identical to PUF3 (and 31% to PUF4), whereas PUF3 is 36% identical to 
PUF4 within that same domain. To perform double RNAi experiments, two different 
strategies were theoretically possible. RNAi fragments for both targets can either be cloned 
into the same RNAi plasmid (p2T7TA-blue) or a second transfection is performed, using a 
plasmid with a different antibiotic resistance. We decided to follow latter strategy. To this 
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end, the hygromycin cassette of p2T7-177 was replaced by a blasticidin resistance cassette, 
generating plasmid pHD1621 (done by Corinna Benz). Subsequent transfections of 
bloodstream cells with the two different RNAi plasmids resulted in a double RNAi cell line 
that can be simultaneously depleted of two distinct PUF transcripts (Fig.3.11.). However, 
these double RNAi cell lines also exhibited normal growth (data not shown).  
 
 
 
3.3. Microarray analysis of PUF strains 
3.3.1. Microarray analysis of PUF RNAi and overexpression strains 
Based on the functions of Drosophila Pumilio and C. elegans FBF, I reasoned that TbPUFs 
would bind to and regulate specific mRNAs, either by altering mRNA stability or 
interfering with translation. Using mRNA degradation assays (Hoek, Zanders et al. 2002) 
suggested that perturbation of TbPUF1 levels affects the stability of several ES-derived 
mRNAs (e.g. VSG221 and ESAG6). These results were, however, somewhat preliminary, 
since loading controls were not applied. Furthermore, the authors emphasized, that the ES-
associated mRNAs need not be the primary targets of TbPUF1. To confirm the results of 
(Hoek, Zanders et al. 2002) and to examine the hypothesis of TbPUF1 being a modulator 
of mRNA stability, I asked if perturbation of PUF protein levels in T. brucei would 
TbPUF1
Fig.3.11. A phylogenetic tree was derived using only 
the PUF domain sequences from the 9 PUF proteins in 
T. brucei. Double RNAi was performed for PUF1/3, 
PUF1/4, and PUF3/PUF4 in bloodstream form cells. 
TbPUF3
TbPUF4
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influence steady-state levels of specific mRNAs. Here I compared global transcript levels 
of T. brucei wild-type cells with cells where PUF-levels had been perturbed (either by 
RNAi or overexpression) using T. brucei specific genomic DNA microarrays (Diehl, Diehl 
et al. 2002; Brems, Guilbride et al. 2005). In brief, total RNA was isolated from cells 
uninduced and induced for RNAi (or overexpression) and reverse transcribed with Cy3 and 
Cy5-labeled dCTP. To prevent bias caused by preferential label incorporation, the two 
CyDyes were swapped between the two types of RNA (uninduced or induced). Six 
independent hybridisations were performed for each PUF RNAi or overexpression cell 
line. Figure 3.12. shows a section of the DNA chip of TbPUF1 RNAi microarray analysis 
in bloodstream and procyclic cells. Software analysis (MCHIPS, (Fellenberg, Hauser et al. 
2001)) showed only the RNAi-downregulated TbPUF1 transcript to be regulated (Table 
3.1.). Similar results were obtained in microarray analysis with TbPUF9 RNAi cells (Table 
3.1.). TbPUF1 and TbPUF9 contain only six and four, respectively, Puf repeats that are 
recognized by Pfam model. I speculated that the presence of all eight Puf repeats might 
necessary for fulfilling physiological function. To this end, I performed microarray 
hybridisations with TbPUF2 and TbPUF6 RNAi procyclic cells. Both proteins bear eight 
Puf repeats that are recognized by Pfam model. However, overall transcript levels also 
remained unaffected in these RNAi strains. 
 
 
 
 
 
 
 
 
 
Since PUF proteins do generally suppress mRNA either by promoting mRNA degradation 
or inhibiting translation we hypothesized that overexpression of PUF proteins in T. brucei 
(Fig.3.13a.) might lead to downregulation of target mRNAs. As observed with the RNAi 
- +
 
- +
 
 TbPUF1 RNAi 
RNA
Protein
- + 
- + 
TbPUF1 RNAi 
RNA
Protein
Fig. 3.12. DNA chip 
spotted with 24,567 PCR 
products (Brems, 
Guilbride et al. 2005). 
Total RNA of TbPUF1 
RNAi-induced (Cy5) and 
uninduced (Cy3) cells 
were compared. A 
section with the down-
regulated PUF1-
transcript (35H11, white 
arrow) in T. brucei 
bloodstream (a, 2.50 fold 
down regulation) and 
procyclics form (b, 2.01) 
is shown. Northern and 
Western blot confirming 
TbPUF1 knockdown are 
shown below. 
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analysis, upregulation of the overexpressed PUF transcript was detected in the microarray 
analysis, again serving as an internal positive control. Notably, transcript levels of a 
specific rRNA spacer region (marked with * in the Table 3.1.) also increased upon 
overexpression of TbPUF1, TbPUF9 (both bf and pc) and TbPUF5 (pc). Subsequent 
analysis revealed that the overexpression plasmid integrated into these rRNA spacer 
regions. However, Northern blot analysis failed to show the differential expression of these 
rRNA transcripts. Interestingly, overexpression of TbPUF5 in procyclic cells resulted in a 
growth defect (Fig.3.13c.) and differential regulation of 14 transcripts (Table 3.1.); nearly 
all upregulated transcripts derived from a locus complementary to the rRNA spacer region 
in the overexpression plasmid. We suspect that the overexpression plasmid integrated 
stably in this region of the genome. Two downregulated spots (clone 08B07 and 50B19) 
corresponded to Tb11.01.7880, a gene encoding CAP17 (corset-associated protein 17). 
Notably, Tb11.01.7880 was already found to be upregulated in procyclics in microarray 
analysis (Diehl, Diehl et al. 2002). To confirm these differentially regulated hits, Northern 
blot analyses were performed. As can appreciated from Fig.3.14., CAP17 mRNA is indeed 
downregulated upon overexpression of TbPUF5 in procyclic cells. However, further 
analysis confirming the putative interaction between TbPUF5 and TbCAP17-mRNA need 
to be done, for example by gel mobility shift assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
71 
Tab.3.1. 
gene 
array  
 
ratio Northern
false 
positive identity 
      
PUF1-o.e. bf 
 13_P_24* 2,55  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
o.e. 
 21_O_07 2,17  x Tb927.3.3421 |||rRNA small subunit 
 
 21_P_03 2,36  x  
 
 33_K_24* 2,23  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 40_P_15* 2,24  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 44_A_08 2,06  x  
 
 47_E_01 2,39  x  
 
      
 
PUF1-o.e. pc 10_A_18* 2,61  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 13_P_24* 2,67  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 14_L_17* 2,25  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 33_H_13* 2,21   rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 33_K_24* 2,22  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 35_H_11 1,55 4,83  TbPUF1, Tb10.70.2800 
 
 40_P_15* 2,24  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
      
 
PUF1-RNAi bf 35_H_11 -2,50 -3,42  TbPUF1, Tb10.70.2800 
 
      
PUF1-RNAi pc 35_H_11 -2,1 -3,09  TbPUF1, Tb10.70.2800 
 
      
PUF9-o.e. bf 35_N_23 3,26 4,27  TbPUF9, Tb927.1.2600  
 
      
PUF9-o.e. pc 35_N_23 3,77 4,58  TbPUF9, Tb927.1.2600 
 
 40_P_15* 1,49  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
      
PUF9-RNAi bf 05_P_19 -2,21  x  
 
 35_N_23 -2,43 -3,09  TbPUF9, Tb927.1.2600  
 
      
 none     
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PUF9-RNAi pc 
 
      
 
PUF5 o.e. pc 02_O_17 -3,16    
 
 05_P_03 -2,54  x Tb927.8.8300, amino acid transporter, putative 
 
 08_B_07 -3,89 -1,82  CAP17_microtubule-associated_protein, Tb11.01.7880 
 
 08_I_03 2,58  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 12_K_21* 10,42 3,50  rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 13_N_02 3,94  x Tb08.27P2.50_|__||hyp._protein| 
 
 13_P_24* 10,66  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 14_L_17 4,38  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 16_G_3 -1,88   Tb09_SLRNA_0005 SL RNA 
 
 18_K_16* 6,87  x Tb927.1.3580 |||hyp. protein, unlikely 
 
 33_A_24 3,08  x Tb10.70.7820 hyp. protein 
 
 33_K_24* 2,31  x  
 
 43_H_11* 3,45  x rRNA_region, Tb927.1.3720, hyp. protein, unlikely 
 
 50_B_19 -2,89 -1,73  CAP17_microtubule-associated_protein, Tb11.01.7880 
 
 58_C_14 2,74   Tb02_rRNA_17||18S_ribosomal_RNA 
abbreviation: o.e., overexpression; hyp., hypothetical 
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Fig.3.13. PUF overexpression in T. 
brucei. A) Northern blot showing that 
recombinant PUF transcripts were 
expressed upon induction with 
tetracycline. B) Western blot of PUF1 
over-expression pc cell line using α-
TbPUF1. C) Growth analysis of 
procyclic PUF5 overexpression cell 
lines. 
C 
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Fig.3.14. Overexpression of TbPUF5 in procyclics cells lead to downregulation of TbCAP17 (corset-
associated protein 17) mRNA. a) Overexpression of TbPUF5 and concomitant downregulation of TbCAP17 
was assessed by Northern blot analysis 48 hrs after tetracycline addition. SRP was used as a loading control. 
b) A section of the DNA chip with the downregulated CAP17 transcript (white arrow) is shown. Left: Cy3 –
Tet/Cy5 +Tet; right Cy3 +Tet/Cy5 –Tet. 
3.3.2. Looking for PUF targets by a combination of affinity purification 
and microarray analysis 
 
Although members of the PUF protein family are widely distributed among eukaryotes, 
only a few of their mRNA targets have been identified so far. Recently, it was 
demonstrated that yeast PUF proteins all interact selectively with distinct groups of 
functionally related mRNAs (Gerber, Herschlag et al. 2004). We have used a similar 
approach, namely affinity purification of PUF proteins and analysis of associated mRNAs 
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by microarray hybridisations. To this end, I C-terminally TAP-tagged TbPUF1, TbPUF5, 
and TbPUF9. The TAP tag (Rigaut, Shevchenko et al. 1999) consists of two IgG-binding 
units of Protein A, a specific protease recognition site, and a calmodulin-binding domain. 
Cell extracts of TAP-tagged strains were prepared, and ribonucleoprotein complexes were 
affinity purified on IgG beads and recovered by subsequent cleavage with tobacco etch 
virus (TEV) protease. The same procedure was performed using cells expressing only the 
TAP tag, serving as a control for non-specifically enriched mRNAs. RNA was isolated 
from the purified protein samples (PUF-TAP and TAP only strains). The two different 
RNA samples were used to prepare cDNA probes labeled with different fluorescent dyes, 
which were mixed and hybridized to T. brucei genomic microarrays (Diehl, Diehl et al. 
2002; Brems, Guilbride et al. 2005). Three microarray hybridisations for two independent 
Puf affinity isolations were performed for PUF9 bf cells and two hybridisations from one 
isolation for PUF1 pc, PUF5 bf and PUF9 pc cells. Preliminary results are shown in Table 
3.2. Microarray analyses with RNA from additional PUF affinity purifications to confirm 
these data will be done. 
 
3.4. Looking for PUF binding partners in T. brucei 
To date, PUF proteins were shown to physically interact with members of three protein 
families (Nanos, CPEB, and Brat). Currently, no homologues of these PUF interactors are 
found in the genome of protozoa. (Hoek, Zanders et al. 2002) suggested that TbPUF1 
interacts with TbESAG8. However, the results showing this interaction were somewhat 
preliminary (see Introduction). Therefore, I used two different methods to look for 
interaction partners, namely the TAP approach and co-immunoprecipitation as described in 
the following sections. 
 
3.4.1. Tandem Affinity Purification of putative PUF interacting partners 
To search for interacting partners I used the tandem affinity purification (TAP) strategy 
introduced by (Rigaut, Shevchenko et al. 1999; Puig, Caspary et al. 2001). Briefly, the 
TAP-tag containing two IgG binding units of Protein A, a tobacco etch virus (TEV) 
protease cleavage site, and a calmodulin binding domain is fused C-terminally to TbPUF1 
and TbPUF9, and TAP-tagged PUF1 (PUF9) expression is induced by the the addition of  
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Table 3.2.      
 
       
 
TAP/RNA       
 
       
 
PUF1-TAP pc       
 
 Isolation #1 Isolation#1     
 
 slide #1 slide#2     
 
01K10 x x  repeat unit   
 
02D11 x x  INGI   
 
02L04 x x  nucleobase/nucleoside transporter 8.1, Tb11.02.1105 
 
03A12 x x     
 
11C13 x x  ATP-dependent phosphofructokinase, Tb927.3.3270 
 
14C01 x x     
 
16D17 x x  MLH1, mismatch repair protein, Tb08.30K1.770 
 
17M19 x x     
 
18O19 x x  ESAG like   
 
21P09 x x  HK1, hexokinase, Tb10.70.5820  
 
22L01 x x     
 
26O18 x x     
 
28C12 x x  Tb927.3.4080, hyp. protein, 14 predicted TM domains 
 
28H10 x x     
 
32H10 x x  INGI   
 
32H14 x x     
 
33J14 x x     
 
35B20 x x     
 
41D22 x x     
 
42K02 x x     
 
44O19 x x  INGI   
 
45N01 x x     
 
45N09 x x     
 
46G04 x x     
 
47A12 x x  rRNA region; Tb927.1.3720, hyp. protein, unlikely 
 
48K23 x x     
 x x  INGI   
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55D23 
 
55H03 x x  ESAG, putative, Tb927.2.2020   
 
56D07 x x     
 
56O4 x x     
 
       
 
       
 
PUF9-TAP bf       
 
 Isolation #1 Isolation #2 Isolation #2   
comment
s 
 
 slide #1 slide #2 slide #3   
in PUF9-
RNAi bf 
 
       
 
05P19 x X X   -2.21 
 
16L12  X X    
 
21N07  X X TbPUF9   
 
22D07 x      
 
22P10  X X   -1.26 
 
28H19       
 
31G22  X X    
 
32E16 x x x   -1.87 
 
32E16  X X    
 
32F10 x X X DNA ligase, Tb07.29K4.760  -1.45 
 
32L04       
 
35F01 x      
 
39O15  X X    
 
40D05 x      
 
48G14  X X    
 
51M11       
 
52L23  X X    
 
55O18  X X    
 
58C08 x X X    
 
PUF5-TAP bf     
  
 
 Isolation #1 Isolation #1   
  
 
 slide #1 slide #2   
 
       
 
01B03 x x     
 
02L12 x x     
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05P03 x x  XUK......NIGDB   
 
08L22 x x     
 
13L21 X X     
 
17P17 x x  amino acid transporter, putative, Tb927.4.3990   
 
18M03 x x  hypothetical protein, unlikely, Tb927.1.2840   
 
24C06 x x     
 
24O07 x x   
 
28L21 x x  Best matches to amino acid transporters 
 
29P10 x x  SLACS reverse transcriptase, putative, Tb09.211.5015   
 
31J08 x x     
 
35H11 X X  TbPUF1, Tb10.70.2800 
 
39L01 x x   
 
40K15 x x  AATP11, aa transporter, putative, Tb927.4.4730    
 
41C09 x x    
 
42G06 x x     
 
48E04 x x  AATP11, aa transporter, putative, Tb927.4.4730  
 
57F07 X X     
 
58J07 x x     
 
     
 
PUF9-TAP pc       
 
       
 
44F20 x x     
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tetracycline (Fig.3.15.). However, attempts to purify binding partners of TbPUF1 and 
TbPUF9 using this method failed. It is possible that binding with the interactors occurs 
only transiently and is therefore impossible to detect by the TAP approach. Another 
possibility is that the TAP tag interferes with binding to the interacting partners. 
Mutational and structural analyses indicate that the C-terminal region of Drosophila 
Pumilio confers binding to two other proteins, Nos and BRAT. Both endogenous PUF1 
(PUF9) alleles have to be deleted to show that TAP-tagged PUF1 (PUF9) is functional. 
This has not been done so far. 
 
Fig.3.15. Figure PUF-TAP. Western blot using PAP antibody which recognizes the TAP-tag (1:1000 dilution 
in 5% milk). Induction with tetracycline leads to expression of TAP-tagged PUF1 (1396) in pc and bf (A) 
and TAP-tagged PUF9 (1456) in pc and bf (B). 
 
 
 
3.4.2. Co-immunoprecipitation using α-TbPUF1 antibody 
 
α-TbPUF1 antibody was coupled to Protein A Sepharose beads (Amersham Biosciences). 
Protein extracts prepared from in vivo 35S methionine radiolabeled cells were incubated 
with α-TbPUF1 coupled beads. Co-immunoprecipitation was performed as described in the 
Materials and Methods section. As a negative control we either used pre-immune serum or 
PUF1-RNAi strain cell extracts (Fig.3.16.). A few bands which were not present in the 
negative control suggested the presence of binding partners. However, attempts to upscale 
the co-immunoprecipitation using more unlabeled cell extracts to obtain suitable amounts 
for mass spectrometry sequencing were not successful. 
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Fig.3.16. Co-immunoprecipitation using α-TbPUF1 coupled sepharose beads. A) Co-immunoprecitpiation 
with 35S metabolically labeled procyclic 427 1313 cells. Pre-immune (PI) serum was used as a negative 
control to assess for non-specific binding to the beads. B) Co-immunoprecipiation with cells uninduced (-tet) 
and induced (+tet) for TbPUF1-RNAi. C) An enlargement of elutions a, b, c, and d. Bands which are only 
present in α-TbPUF1 co-IP compared to PI co-IP are indicated with arrows. 
 
3.5. Localization of TbPUF9 and TbPUF5 
To date all characterized PUF proteins reside in the cytoplasm, this being consistent with 
their role in translational control. To investigate the localization of TbPUF9, 
immunofluorescence assays were performed. TAP tagged TbPUF9 is predominantly 
localized to the cytosol in both bloodstream and procyclic stage with a higher 
concentration at the perinuclear space (Fig.3.17.). Despite a mitochondrial localization 
signal as predicted by the program ESLpred (Bhasin and Raghava 2004), TbPUF5 is also 
localized to the cytosol, even though interestingly the protein is concentrated at discrete 
foci, a pattern which was also observed for HA-tagged PUF1 in T. brucei bloodstream 
form (Hoek, Zanders et al. 2002) and His-tagged TcPUF6 in T. cruzi (Dallagiovanna, Perez 
et al. 2005). In yeast each of the five members of the PUF-family is associated with 
specific mRNAs at discrete locations in the cytoplasm (Gerber, Herschlag et al. 2004). It is 
possible that in T. brucei, too, PUF proteins act at discrete foci. However, testing this 
hypothesis would go beyond the scope of this work. 
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Fig.3.17. Subcellular localization of TAP-tagged TbPUF1 and TbPUF9 in procyclic (pc) and bloodstream 
(bf) form cells, and of TAP-tagged TbPUF5 in bf cells. DAPI was used to stain the nucleus and the 
kinetoplast. Anti ProteinA antibody was used to detect the TAP-tagged PUF proteins. An overlay of both 
images is shown on the right panel. 
 
TbPUF5 bears a mitochondrial localization signal. To assess the possibility of a 
mitochondrial localization of TbPUF5, immunofluorescene analysis was performed 
(Fig.3.18.). To this end, bloodstream form cells expressing TAP-tagged TbPUF5 were 
incubated with MitoTracker Red CMXRos (Molecular Probes) at a final concentration of 
Results 
82 
0.5µM. The cells were incubated for 10 min. in an open tube in a gassed incubator (5% 
CO2), then centrifuged and washed with HMI-9 and reincubated without dye for 20 min. 
The cells were then fixed for indirect immunofluorescence as described in the Materials & 
Methods section (2.9.). 
 
 
Fig.3.18. No co-localization can be observed for the mitochondrium (stained with mitotracker) and TAP-
tagged TbPUF5. 
 
 
3.6. Testing PUF protein function without knowing the target 
To investigate a putative role for PUF protein in gene expression in T. brucei independent 
of target identity we have adopted the method of tethered function analysis developed by 
(Coller, Gray et al. 1998) and discussed in more detail by (Coller and Wickens 2002). To 
this end, a chimeric protein consisting of λN linked to TbPUF1 (or TbPUF9) was 
expressed in T. brucei procyclic cells; the same strain also carried a second plasmid 
expressing the CAT (chloramphenicol acetyl transferase) reporter mRNA with six λN 
recognition sites in its 3’-UTR. Binding of λN to the boxB element brings the PUF protein 
in close proximity of the reporter mRNA (Fig.3.19.). Having such a system in our hands, 
we were then able to assay the biological functions of the tethered PUF protein in terms of 
mRNA stability modulation (using Northern blot analysis) and control of translation 
(Western blot and CAT assay) (Fig.3.19.). Northern blot analysis showed that PUF1-λN 
and PUF9-λN transcripts were expressed - although to somewhat lower level in the PUF1 
strain - and that CAT mRNA level stayed constant. However, when looking at the protein 
level, we were surprised to see that CAT protein amount had increased by about 2-fold in 
cells where PUF9-λN was expressed, whereas CAT protein expression was not influenced 
by the expression of PUF1-λN. Furthermore, these results from the Western blot analysis 
were confirmed by measurement of the CAT activity (Fig.3.20.). We do not know why 
PUF9 seems to promote translation, since all PUF proteins studied so far have a repressing 
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function. Obviously, a lack of results in a tethered function assay does not lead to any 
conclusions. At the same time, results acquired in such an assay should be treated with 
care, since a tethered function assay system represents a rather artificial situation.   
 
 
 
 
 
 
 
 
 
 
Fig.3.19. Binding of the λN-peptide to the boxB element in the 3’-UTR of the chloramphenicol acetyl 
transferase mRNA brings the PUF protein in close proximity of the reporter mRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.20. Tethered function analysis using tethered PUF protein. a) Northern blot showing that a chimeric 
puf1-λN (puf9-λN) transcript was expressed upon induction with tetracycline. Endogenous puf transcript 
remained constant. CAT mRNA is slightly increased in puf1-λN induced cells. b) Western blot analysis 
showing that CAT protein level remains unchanged for PUF1 but increased for PUF9. CSM (cytosolic 
marker is used as loading control. c) CAT activity assay confirming the results from b). 
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3.7. A role for PUF proteins in translational control in 
Trypanosoma brucei 
 
PUF proteins have been shown to be involved in mRNA stability modulation as well as in 
translational control. To test the latter function in T. brucei we asked whether perturbation 
of PUF protein level would result in altered translational control and therefore differential 
protein expression of target mRNAs. Two-dimensional gel electrophoresis has become a 
powerful method to study global gene expression on the protein level. However, 
comparing different proteomes by classical two-dimensional electrophoresis is challenging 
and often complicated by substantial gel-to-gel variation. Separating two or more protein 
samples labeled with different fluorescent dyes in one single gel, as in two-dimensional 
difference gel electrophoresis (DIGE), reduces this variability considerably. To this end, 
we have applied the DIGE system (Amersham Biosciences) to compare the global protein 
levels of T. brucei wild-type cells with TbPUF1 knockout cells, and cells uninduced versus 
induced for PUF RNAi. In addition we performed DIGE analysis with 427 1313 514 bf 
and pc cells treated and untreated with tetracycline to assess the possibility that the drug 
per se is controlling translation. Two independent DIGE analyses were performed for each 
cell line. As can be seen in the tetracycline control, incubation of the cell culture with this 
drug for 48 hours does not lead to changes in global protein expression level, nor up- or 
downregulation of specific proteins (Fig.3.21a.). Only one protein was differentially 
expressed upon depletion of TbPUF1 in bloodstream form cells (Fig.3.21b.), whereas four 
proteins were downregulated in the ∆PUF1 procyclic cell line compared to wild-type cells 
(Fig.3.21c.). No differences on protein levels were apparent when comparing TbPUF9 
RNAi uninduced and induced procyclic cells (Fig.3.21d.), and one protein (tryparedoxin) 
was downregulated when depleting TbPUF9 in bloodstream form cells (Fig.3.21d.). 
However, Western blot analysis of PUF9-RNAi cells using α-tryparedoxin antibody did 
not confirm DIGE results. 
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Fig.3.21a. DIGE analysis with tetracycline induced 427 procyclic (A) and bloodstream form (B) cells 
bearing the tet repressor (1313) and a T7-polymerase (514). Protein extract from uninduced (-tet) and 
induced (+tet) cells were labelled with Cy5 and Cy3, respectively. Both protein samples were mixed and 
loaded onto the same 2-dimensional gel. 
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Fig.3.21b. DIGE analysis of TbPUF1-RNAi (1538) bloodstream form cell lines. Cell extracts from 
uninduced (-tet) and induced (+tet) cells were labeled with Cy5 and Cy3, respectively. Enlargments of A and 
B are shown. C and D are 3D representations of the spot-intensity. E and F show comparison between the 
analytical gel (Cy3) and the preparative gel (stained with Sypro Orange). The spot of interest is highlighted in 
red and after mass spectrometry was identified as a putative phosphatidyl inositol kinase domain protein.  
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Fig.3.21c. DIGE analysis comparing wild-type procyclic cells (Cy5) with 427 ∆PUF1 pc cells (Cy3). The 
identity of the differentially regulated proteins are: A) tryparedoxin peroxidase (Tb09.160.4250 199aa, 
22.4kD, pI 6.4); B) heat-shock protein 70 (Tb11.01.3110, 690aa, 75.3 kD, pI 6.3); C) ribonucleoprotein, p18, 
mitochondrial precursor, putative, Tb927.5.1710, 188aa, 21.2kDa, pI 6.7); D) S-adenosylmethionine 
synthetase, Tb927.6.4840, 397aa, 43.5kD, pI 5.9). 
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3.21d. DIGE analysis of PUF9-RNAi (1489) pc (A) 
and bf (B) cells. The differentially regulated protein in 
B is enlarged (C), Tryparedoxin (Tb927.3.3780, 
144aa, 15,8kD, pI 4.8). (D) Western blot of wild-type 
and PUF9-RNAi pc and bf form cells using α-
tryparedoxin antibody (gift of L. Krauth-Siegel). 
C (Cy5) C (Cy3) 
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3.8. TbPUF1 is not associated with polyribosomes 
Since preliminary DIGE analysis suggested a role for PUF proteins in translational control, 
I wanted to investigate whether TbPUF1 might be associated with polysomes. To this end, 
polysomal fractionation of bloodstream form cells was performed. As can be appreciated 
from the A254 profile (Fig.3.22a.) polysomes were separated from the 80S monosomes and 
soluble material. Western blot analysis was performed using α-PABP1 antibody to assess 
for the presence of polysomes (Fig.3.22b.). TbPUF1 did not cosediment with 
polyribosomes. 
 
 
Fig.3.22. TbPUF1 does not cosediment with polyribosomes. Sucrose density gradient analysis of cytoplasmic 
extracts from Trypanosoma brucei bloodstream form cells. (a) Absorbance profile at 254 nm; the positions of 
the 80S monosome and polyribosomes are indicated. (b) Western blot analysis using α-TbPUF1, α-PABP, 
and α-DHH1 antibody. 
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4. Discussion 
 
Two lines of evidence form the basis of this work. First, the phenomenon that gene 
expression in Trypanosoma brucei almost entirely depends on post-transcriptional control. 
Second, the existence of a family of RNA-binding proteins, which exactly perform this 
role, namely post-transcriptional gene regulation by promoting mRNA degradation and 
interfering with translation. 
 
From a naive and somewhat unbiased point of view, PUF proteins could have any possible 
biological functions in T. brucei, e.g. control of life-cycle, stress response, and cell cycle; 
they could regulate cytokinesis or certain signal transduction pathways, and they could 
even be implicated in antigenic variation and editing, two processes characteristic to 
Kinetoplastids. However, based on the biological functions of PUF proteins that have been 
studied so far, it was found that all of them are involved in regulation of gene expression, 
and many of them are implicated in developmental control. The first two members of this 
protein family to be characterized in detail were Drosophila Pumilio and C. elegans FBF. 
PUF proteins are found in animals, plants, and fungi. The high degree of sequence 
conservation of the PUM RNA-binding domain in other far-flung species such as 
kinetoplastids suggests that the domain is an ancient protein motif, and generally 
conservation of sequence reflects conservation of function. Most of the discoveries 
concerning PUF protein functions have been acquired in the model organisms yeast, C. 
elegans and Drosophila. So far, nothing is known about the presence of PUF proteins in 
Archaea or eubacteria. 
 
TbPUF1 was the first member of this family described in an early branching eukaryote 
(Hoek, Zanders et al. 2002). The observation that most organisms in which PUF proteins 
have been studied have multiple PUF members lead us to look for other PUF proteins in T. 
brucei. With the recently completed predicted proteome of T. brucei (Berriman, Ghedin et 
al. 2005) and the help of database mining the presence of eight additional PUF proteins 
became apparent. The high number of PUF protein members in T. brucei is in line with the 
observation that more primitive organisms, such as lower eukaryotes, including C. elegans 
and S. cerevisiae possess mutliple PUF proteins, whereas higher organisms (e.g. 
vertebrates) have only one or two. Only four T. brucei PUF proteins (PUF2, PUF3, PUF4, 
and PUF6) have a full set of eight characteristic PUF repeats. Some PUF repeat sequences 
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are somewhat divergent from the consensus, and are therefore not recognized by Pfam 
model. For example TbPUF7 and TbPUF8 are most divergent within T. brucei. Their Puf 
repeats are most divergent from the consensus sequence with major insertions between and 
even within the Puf repeats. On the other hand the divergence between the Puf domains 
within TbPUFs may imply that they bind related but distinct mRNA targets and have 
different roles during parasite development. Recent studies showed that two C. elegans 
PUF proteins, FBF and PUF-8, differ in their RNA-binding specificity which is due to the 
presence or absence, respectively, of only a single nucleotide in their binding sites 
(Opperman, Hook et al. 2005). In this context, it is intriguing to think, that deviations from 
the consensus repeat sequence (e.g. in TbPUF7 and TbPUF8) might lead to disortion of the 
Puf repeats and altered RNA binding specifity. The smaller PUF proteins in T. brucei (e.g. 
TbPUF5) appear to consist exclusively of the PUF domain. Since this domain was 
demonstrated to be necessary and sufficient to exert the proteins functions, it is expected 
that all PUF proteins in T. brucei are indeed functional. For example, the PUF domain of 
yeast Puf1p and Puf2p contains only six Puf repeats recognized by Pfam model (Tadauchi, 
Matsumoto et al. 2001). In the T. brucei PUF proteins, as with PUFs in general, the Puf 
repeat region is near the carboxyl terminus and the proteins diverge toward the amino 
terminus. Except for the conserved PUF domains, the TbPUF proteins differ considerably. 
So far, nothing is known about the role of the N-terminal region. It has been reported that 
PUF proteins of different species, human, mouse, and Xenopus bind to the Drosophila 
hunchback Nanos Response Element (NRE) in vitro. So far, RNA binding activity of 
kinetoplastid PUF proteins has only been shown for TcPUF1 (previously named TcPUF6), 
the TbPUF1 homologue in T. cruzi (Dallagiovanna, Perez et al. 2005). Plasmodium 
falciparum also has two PUF proteins (PfPUF1 and PfPUF2), which were demonstrated to 
bind the NRE of hunchback in vitro (Cui, Fan et al. 2002; Fan, Li et al. 2004). 
 
Interestingly, each of the TbPUFs has a homologue in T. cruzi and L. major. Highest 
homology exists within the PUF8 group with 62% and 52% identity between TbPUF8 and 
TcPUF8, and TbPUF8 and LmPUF8, respectively. The protein sequence of PUF4 is least 
conserved among the three species. Overall, T. brucei PUF proteins are more similar to 
their T. cruzi than to their L. major orthologue. Notably, the PUF proteins are not only 
highly conserved among Tritryps, but also their genes share high conservation of synteny. 
For example the downstream gene of PUF9 in all three pathogens codes for an exosome 
associated protein EAP1, which is an Rrp42 homologue similar to RNasePH proteins in 
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bacteria. The upstream gene of PUF7 in the Tritryp genome codes for a zinc finger protein 
2. The high degree of sequence conservation and synteny among Tritryp PUF proteins 
suggest that they not only share a similar protein structure but also exert similar functions 
in each of the three pathogens. PUF proteins might have evolved very early in the 
eukaryotic evolution, possibly at the time when kinetoplastids branched from the 
eukaryotic lineage. A phylogenetic tree showing the relationship between 90 PUF proteins 
shows that no clear clustering can be drawn for kinetoplastid PUF protein family members, 
as is true for yeast PUF proteins. Notably, the few vertebrate PUF proteins that have been 
identified so far form a distinct group which is most related to dipteran PUF proteins. With 
the exception of PUF-8 and PUF-9, all C. elegans PUF proteins belong to one group. No 
clear separation between plant and animal PUF proteins can not be drawn, a was 
previously done comparing only 34 PUF proteins (Cui, Fan et al. 2002). Overall, one could 
speculate that PUF proteins might have lost their diversity in the course of the evolution. 
 
To investigate the role of PUF proteins in T. brucei, RNAi knockdown was performed for 
each PUF protein in bloodstream and procyclic form cells. It should be noted, that RNAi in 
this case did not lead to a 100% depletion of the PUF transcripts. Residual PUF transcript 
(and concomitantly residual protein) was present in all RNAi induced cell lines, even after 
a prolonged induction of RNAi or incubation with higher tetracycline concentration. With 
this caveat, none of the nine PUF proteins appears to be essential for the in vitro growth of 
T. brucei. It is possible, that they do play a role in differentiation, as this holds true for 
many organisms where PUF proteins have been studied. For example, Pumilio prevents 
female Drosophila germline stem cells from differentiating prematurely as cystoblasts (Lin 
and Spradling 1997; Forbes and Lehmann 1998), and C. elegans FBF  regulates the switch 
from spermatogenesis to oogenesis and also the maintenance of germline stem cells 
(Zhang, Gallegos et al. 1997; Crittenden, Bernstein et al. 2002). In this sense, it should be 
noted that the T. brucei cell lines used in this work are monomorphic, i.e. they have lost the 
ability to differentiate from one life stage (bloodstream) to the other (procyclic form) or 
vice versa. On the other hand most of the reverse genetics (e.g. tetracycline inducible 
RNAi) can only be performed in these monomorphic strains. A circumvention of this 
dilemma could be the use of synthetic siRNAs, which were recently shown to be functional 
in the parasite (Best, Handoko et al. 2005). Thus, pleiomorphic cell lines could be depleted 
of PUF proteins using this technique. 
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It is possible that residual protein due to incomplete efficiency of RNAi could still be 
sufficient to exert normal cellular function. To check this possibility, a TbPUF1 knockout 
was performed in procyclic cells. Surprisingly, deletion of the TbPUF1 gene was not lethal 
for procyclic cells, and growth was not affected. This contradicts the results of (Hoek, 
Zanders et al. 2002). The authors of this work concluded, based on a failure to generate 
PUF1 knockout cell lines, that this gene is essential. Furthermore, they showed, that either 
over- or under-expression of PUF1 reduces growth in culture (Hoek, Zanders et al. 2002), 
a phenotype which was not observed with our PUF1 RNAi and overexpression cell lines. 
To test the hypothesis of PUF1 being involved in differentiation, I tried to knock out PUF1 
in a pleiomorphic (Antat1.1) bloodstream form cell line. However, several attempts to do 
this failed. 
 
Since T. brucei possesses multiple PUF proteins, it is possible that they share redundant 
functions. This hypothesis is based on several lines of evidence. In C. elegans, the two 
nearly identical (>90%) PUF proteins, FBF-1 and FBF-2, which together are called FBF 
(‘fem-3 mRNA binding factor’) share redundant functions as regulators of germline stem 
cell maintainenance (Crittenden, Bernstein et al. 2002; Lamont, Crittenden et al. 2004). 
Furthermore, a very recent work by (Bachorik and Kimble 2005) demonstrated that FBF-1 
and PUF-8 are redundant in their capacities to control the hermaphrodite sperm/oocyte 
switch in C. elegans. Since most work so far has been done for TbPUF1, the idea was to 
simultaneously knock-down another PUF protein which is most related to PUF1. 
Phylogenetic analysis revealed that PUF3 and PUF4 are most likely to share redundant 
function with PUF1 and with each other. Simultaneous depletion of PUF1/PUF3, 
PUF1/PUF4, and PUF3/PUF4 pairs in bloodstream form cells were performed, but these 
cell lines also exhibited normal growth. Of course, RNAi double knockdown of other PUF 
pairs could be done, and even a triple knockdown would be theoretically feasible. 
However, the possibility that residual protein due to incomplete efficiency of RNAi could 
still be sufficient to exert normal cellular function led me to abandon the RNAi approach 
and instead look for mRNA targets using the RNAi strains which were already generated. 
 
Drosophila Pumilio and C. elegans FBF bind to and regulate specific mRNAs, either by 
promoting mRNA degradation or inhibiting translation. Furthermore, using microarray 
approaches it was demonstrated that yeast strains which lack all five PUF proteins showed 
differential expression of several yeast mRNAs (Olivas and Parker 2000). The same work 
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also showed that one of these five yeast PUF proteins, Puf3p, promotes deadenylation and 
concomitant degradation of COX17 mRNA. Preliminary results in T. brucei suggested that 
TbPUF1 is involved in mRNA-stability regulation of several ES-derived mRNAs (e.g. 
VSG221 and ESAG6). However, the authors emphasized, that the ES-associated mRNAs 
need not be the primary targets of TbPUF1 (Hoek, Zanders et al. 2002). Based on these 
observations, the question was whether TbPUF1 is indeed a modulator of mRNA stability 
and whether perturbation of PUF protein levels in T. brucei would influence steady-state 
levels of specific mRNAs. The method of choice to investigate this question was the use of 
T. brucei genomic DNA microarrays which have been used in other transcriptome studies 
(Diehl, Diehl et al. 2002; Brems, Guilbride et al. 2005). To this end, I employed DNA 
microarrays to compare global transcript levels of T. brucei wild-type cells with cells 
where PUF-levels had been perturbed (either by RNAi or overexpression). Notably, only 
the RNAi-downregulated TbPUF1 transcript was shown to be differentially regulated in 
the microarray analysis, again contradicting the results from (Hoek, Zanders et al. 2002) 
mentioned above. Similar results were obtained when studying the transcriptome level of 
TbPUF9 RNAi cell lines. On the one hand, it is somewhat remarkable, that one single 
transcript could be detected emphasizing the high integrity of these DNA chips. On the 
other hand, we were surprised not to see additional differentially regulated transcripts that 
could be targets of TbPUF1 or TbPUF9. 
 
Since PUF proteins do generally suppress mRNA we hypothesized that overexpression of 
PUF proteins in T. brucei might lead to higher turnover of target mRNAs. As observed 
with the RNAi analysis, upregulation of the overexpressed PUF transcript was detected in 
the microarray analysis, again serving as an internal positive control. Notably, transcript 
levels of specific rRNA spacer region also increased upon overexpression of TbPUF1, 
TbPUF5, and TbPUF9. Subsequent analysis revealed that the overexpression plasmid 
integrated into these rRNA spacer regions. However, Northern blot analysis failed to show 
the differential expression of these rRNA transcripts. It is not understood, why differential 
expression cannot be observed in the Northern blot analyses. One explanation could be that 
these rRNA transcripts are too small to be detected on a Northern blot analysis. Notably, 
when overexpressing TbPUF5 in procyclic cells, CAP17 mRNA was downregulated. 
CAP17 transcript was already found to be upregulated in procyclics in microarray analysis 
(Diehl, Diehl et al. 2002). CAP17 (corset-associated protein 17) is differentially expressed 
in the life cycle of T. brucei and when overexpressed it induces morphological disorders 
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and disruptions of processes of the cell cycle (Vedrenne, Giroud et al. 2002). It is not clear, 
whether the growth phenotype of procyclic PUF5 overexpression cell lines is caused by 
downregulation of CAP17. Unfortunately, attempts to generate T. brucei procyclic cell 
lines that express a tagged version of PUF5 have failed so far. Once such a cell line is 
established, it will be possible to investigate whether CAP17 mRNA is associated with 
TbPUF5 in a messenger ribonucleoprotein (mRNP) complex. Additionally, electrophoretic 
gel mobility shift assay with recombinant TbPUF5 protein and radioactively labeled 
CAP17 mRNA would confirm this putative interaction. 
 
Although members of the PUF protein family are widely spread throughout eukaryotes, 
only a few of their targets have been identified so far. Examples of specific interactions 
between PUF protein and mRNA are Drosophila PUM and hunchback mRNA, FBFs and 
fem-3 and gld-1 mRNA, respectively, and Puf3p and COX17 mRNA (Wickens, Bernstein 
et al. 2002). In vitro RNA binding activity has been shown for three parasite PUF proteins, 
Trypanosoma cruzi TcPUF6 (Dallagiovanna, Perez et al. 2005), Plasmodium falciparum 
PfPUF1 (Cui, Fan et al. 2002) and PfPUF2 (Fan, Li et al. 2004). However, it has to be 
emphasized that in all three cases, the bound mRNA (hunchback) was not the endogenous 
target. In yeast, each of the five PUF proteins associates specifically with distinct groups of 
functionally and cytotopically related mRNAs (Gerber, Herschlag et al. 2004). To 
investigate whether this also holds true for T. brucei PUF proteins, I have adopted a similar 
approach, namely a combination of affinity purification of tagged PUF proteins and 
microarray analysis of RNA that are associated with the purified mRNP complexes. 
Preliminary results indicated that PUF5 selectively associates with amino acid transporter 
mRNAs in bloodstream form cells. Interestingly, PUF1 mRNA was also enriched during 
this mRNP purification. It is intriguing to think, that PUF proteins might regulate 
themselves. But much more work has to be done, to underlie this hypothesis. However, the 
vast majority of bound mRNAs has not yet been identified by sequencing of the genomic 
clones. This will be done together with additional mRNP purifications confirming specific 
PUF-mRNA interaction. However, a drawback of this large-scale approach, the possibility 
that PUF proteins bind their physiological targets only transiently and under certain 
conditions, has to be taken into account. 
 
So far, PUF proteins were shown to interact with members of three protein families 
(Nanos, CPEB, and Brat). No homologues of these PUF interactors are found in the 
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genome of protozoa. Interaction of TbPUF1 and TbESAG8 was demonstrated by (Hoek, 
Zanders et al. 2002), however this result were somewhat preliminary. To look for TbPUF1 
and TbPUF9 binding partners I have used the tandem affinity purification (TAP) approach. 
This method, as well as co-immunoprecipitation strategies, have failed to identify TbPUF1 
interaction partners. It is possible that binding with the interactors is only transient and 
therefore not possible to detect by the TAP approach. Another possibility is that the TAP 
tag interferes with binding to the interacting partners. Mutational and structural analyses 
indicate that the carboxy-terminal region of Drosophila Pumilio confers binding to two 
other proteins, Nos and BRAT. Both endogenous PUF1 (PUF9) alleles have to be deleted 
to show that TAP-tagged PUF1 (PUF9) is functional. This has not been done so far. 
 
TbPUF1 is localized to the cytosol (Hoek, Zanders et al. 2002). TAP-tagged TbPUF5 in 
bloodstream form also resides in the cytoplasm, with a somewhat uneven distribution. This 
pattern can also be observed for TbPUF9-TAP in both bloodstream and procyclic forms. 
Obviously, the considerably large tag could interfere with the physiological localization. It 
should be noted, that all tagged PUF proteins are overexpressed, and that unphysiological 
protein level can also cause protein mislocalization. In yeast each of the five members of 
the PUF-familiy is associated with specific mRNAs at discrete locations in the cytoplasm 
(Gerber, Herschlag et al. 2004). It is possible that in T. brucei, too, PUF proteins act at 
distinct locations. Further studies to underlie this hypothesis have to be performed. 
 
So far, only a few mRNA targets for T. brucei PUF1, PUF5, and PUF9 were found using 
microarray analysis and mRNP affinity purification approaches. However, these results are 
somewhat preliminary, and the possibility of missed mRNA targets should not be 
underestimated. To study the role of PUF proteins in T. brucei without the identity of an 
mRNA target, we have adopted the method of tethered function analysis developed by 
(Coller and Wickens 2002). In this approach the PUF protein is brought into close 
proximity of a reporter (CAT, chloramphenicol acetyl transferase) mRNA, which is then 
assayed for mRNA stability and translatability. Northern blot analysis showed that neither 
PUF1 nor PUF9 influenced the stability of the reporter mRNA. However, Western blot 
analysis and CAT activity assays indicated that PUF9 increases translation, something 
which was not observed for PUF1. These results were surprising because all PUF proteins 
studied so far have a repressing function, i.e. promoting mRNA degradation or interfering 
with translation. 
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The possibility that PUF proteins are involved in translational control in T. brucei was 
further investigated by two-dimensional (2-D) gel electrophoresis approaches. Due to 
substantial gel-to-gel variation when using classical 2-D gel electrophoresis systems, I took 
advantage of the new DIGE system (described in section 2.14.). Preliminary results 
showed that incubation of T. brucei culture with tetracycline had no effect on global 
protein expression levels nor differential regulation of specific proteins. One protein, a 
putative phosphatidyl inositol kinase domain protein, was upregulated when depleting 
PUF1 in bloodstream form cells, and four proteins (tryparedoxin peroxidase, heat-shock 
protein 70, ribonucleoprotein p18, and S-adenosylmethionine synthetase) were 
downregulated in the procyclic PUF1 knockout cell line. 
 
The work of this thesis, the characterization of PUF proteins and their role in gene 
expression in T. brucei has set the foundation for future work concerning this family of 
RNA-binding proteins. The unique position of trypanosomes in the eukaryotic evolution 
means that the study of this –or other protein families- is vital in determining its 
evolutionary conservation, and hence its importance. 
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5. General abbreviations 
 
aa  amino acid 
Amp  ampicillin 
APS  ammonium persulfate 
ATP  adenosine-5-triosephosphate 
bf  bloodstream form 
bp  base pairs 
BSA  Bovine Serum Albumin 
bsd  blasticidin 
CAT  chloramphenicol acetyl tranferase 
DAPI  4’, 6’-diamidino-2-phenylindole 
dATP  2’-deoxyadenosine 5’-triphosphate 
dCTP  2’-deoxycytidine 5’-triphosphate 
DEPC  diethyl pyrocarbonate 
dGTP  2’-deoxyguanosine 5’-triphosphate 
DIGE  differential gel electrophoresis 
DNA  deoxyribonucleic acid 
dNTP  deoxyribonucleoside triphosphates 
dsRNA double-stranded RNA 
DTT  1,4-Dithiothreitol 
dTTP  2’-deoxythymidine 5’-triphosphate 
E. coli  Escherichia coli 
EDTA  ethylenedinitrilo tetraacetic acid 
et al.  and others 
ESAG  expression site associated gene 
FCS  fetal calf serum 
fig.  figure 
hyg  hyrgomycin 
IPTG  isopropyl-β-D-thiogalactopyranoside 
kb  kilobase 
kD  kilo Dalton 
kDNA  kinetoplast DNA 
LB  Luria-Bertani 
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MOPS  3-(N-morpholino) propane sulfonic acid 
mRNA messenger RNA 
mRNP  messenger ribonucleoprotein 
neo  neomycin 
nt  nucleotide 
OD  optical density 
ORF  open reading frame 
PAGE  polyacrylamide gel electrophoresis 
PBS   phosphate-buffered saline 
pBS  plasmid Bluescript 
pc  procyclic 
PCR  polymerase chain reaction 
pH  -log [H+] 
phleo  phleomycin 
pI  isoelectric point 
RBP  RNA binding protein 
RNA  ribonucleic acid 
RNAi  RNA interference 
RNA pol RNA polymerase 
RNase  ribonuclease 
rpm  rounds per minute 
RRM  RNA recognition motif 
rRNA  ribosomal RNA 
RT  room temperature 
SDS  sodium dodecyl sulfate 
SL  spliced leader 
SSC  saline sodium citrate 
spp  subspecies 
TAE  Tris-acetate-EDTA 
TAP  tandem affinity purification 
TCA  tricarboxylic acid 
TE  Tris-EDTA 
TEMED N,N,N’,N’-tetramethylethylenediamide 
tet  tetracycline 
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Tris  tris(hydroxymethyl)aminomethane 
tRNA  transfer RNA 
U, u  unit 
UTR  untranslated region 
UV  ultraviolet 
Vol  volume 
VSG  various surface glycoprotein 
wt  wild-type 
w/v  weight/volume 
X-Gal  5-bromo-4chloro-3-indolyl-β-D-galactosidas
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